This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotani, K.
Right arrow Articles by Kasuga, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotani, K.
Right arrow Articles by Kasuga, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 1998, p. 6971-6982, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Requirement of Atypical Protein Kinase Clambda for Insulin Stimulation of Glucose Uptake but Not for Akt Activation in 3T3-L1 Adipocytes

Ko Kotani,1 Wataru Ogawa,1,* Michihiro Matsumoto,1 Tadahiro Kitamura,1 Hiroshi Sakaue,1 Yasuhisa Hino,1 Kazuaki Miyake,1 Wataru Sano,1 Kazunori Akimoto,2 Shigeo Ohno,2 and Masato Kasuga1

Second Department of Internal Medicine, Kobe University School of Medicine, Chuo-ku, Kobe 650-0017,1 and Department of Molecular Biology, Yokohama City University School of Medicine, Kanazawa-ku, Yokohama 236-0004,2 Japan

Received 25 February 1998/Returned for modification 15 April 1998/Accepted 14 August 1998

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Phosphoinositide (PI) 3-kinase contributes to a wide variety of biological actions, including insulin stimulation of glucose transport in adipocytes. Both Akt (protein kinase B), a serine-threonine kinase with a pleckstrin homology domain, and atypical isoforms of protein kinase C (PKCzeta and PKClambda ) have been implicated as downstream effectors of PI 3-kinase. Endogenous or transfected PKClambda in 3T3-L1 adipocytes or CHO cells has now been shown to be activated by insulin in a manner sensitive to inhibitors of PI 3-kinase (wortmannin and a dominant negative mutant of PI 3-kinase). Overexpression of kinase-deficient mutants of PKClambda (lambda KD or lambda Delta NKD), achieved with the use of adenovirus-mediated gene transfer, resulted in inhibition of insulin activation of PKClambda , indicating that these mutants exert dominant negative effects. Insulin-stimulated glucose uptake and translocation of the glucose transporter GLUT4 to the plasma membrane, but not growth hormone- or hyperosmolarity-induced glucose uptake, were inhibited by lambda KD or lambda Delta NKD in a dose-dependent manner. The maximal inhibition of insulin-induced glucose uptake achieved by the dominant negative mutants of PKClambda was ~50 to 60%. These mutants did not inhibit insulin-induced activation of Akt. A PKClambda mutant that lacks the pseudosubstrate domain (lambda Delta PD) exhibited markedly increased kinase activity relative to that of the wild-type enzyme, and expression of lambda Delta PD in quiescent 3T3-L1 adipocytes resulted in the stimulation of glucose uptake and translocation of GLUT4 but not in the activation of Akt. Furthermore, overexpression of an Akt mutant in which the phosphorylation sites targeted by growth factors are replaced by alanine resulted in inhibition of insulin-induced activation of Akt but not of PKClambda . These results suggest that insulin-elicited signals that pass through PI 3-kinase subsequently diverge into at least two independent pathways, an Akt pathway and a PKClambda pathway, and that the latter pathway contributes, at least in part, to insulin stimulation of glucose uptake in 3T3-L1 adipocytes.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Phosphoinositide (PI) 3-kinase, a lipid kinase composed of an SRC homology 2 (SH2) domain-containing regulatory subunit and a 110-kDa catalytic subunit, catalyzes phosphorylation of the D3 position of PIs (46, 48). This enzyme was first identified complexed with SRC kinase and the middle T antigen of polyomavirus and was later found to associate with various tyrosine-phosphorylated proteins in response to stimulation of cells with growth factors or cytokines (46, 48). Activation of PI 3-kinase, either by targeting of the enzyme to the plasma membrane (27) or as a consequence of direct interaction between the SH2 domain of the regulatory subunit and phosphorylated tyrosine residues present within specific motifs (5), results in the triggering of various important biological actions. Thus, with the use of either a dominant negative protein that blocks the interaction between PI 3-kinase and tyrosine-phosphorylated proteins (21, 33, 41) or pharmacological inhibitors of the enzyme, such as wortmannin or LY294002 (12, 47), PI 3-kinase has been shown to participate in intracellular trafficking, organization of the cytoskeleton, cell growth and transformation, prevention of apoptosis, cell differentiation, and several metabolic actions of insulin (11, 17, 23, 24, 33, 41, 46, 48). However, relatively little is known about the downstream effectors of PI 3-kinase that mediate each of these biological effects.

Recently, two types of serine-threonine kinase have been shown to act downstream of PI 3-kinase. One of these kinases is Akt (also known as protein kinase B), which contains a pleckstrin homology domain. Several growth factors induce rapid activation of Akt in intact cells (10, 16, 28). However, the mechanism of Akt activation in cells is not fully understood. Phosphatidylinositol 3,4-bisphosphate, one of the products of PI 3-kinase activity in vivo, binds directly to the pleckstrin homology domain of Akt and stimulates kinase activity in vitro (18, 28), suggesting that Akt may be directly activated by this lipid in intact cells. On the other hand, activation of Akt was shown to parallel its phosphorylation status, and replacement of serine and threonine residues that are sites of ligand-induced phosphorylation in the enzyme abolished its activation (3, 31). These data, together with the identification of a kinase that phosphorylates and activates Akt (4, 44), suggest that Akt activity is regulated mainly by phosphorylation. Whichever mechanism is primarily responsible for regulation of Akt, the observation that pharmacological or molecular biological inhibitors of PI 3-kinase prevent Akt activation in intact cells (10, 16, 26, 29) indicates that Akt acts downstream of PI 3-kinase.

The protein kinase C (PKC) family of serine-threonine kinases comprises at least 11 members (37). One class of PKC isozymes, termed atypical PKC, is distinct from other members of this family in several respects. For example, the atypical PKC enzymes, consisting of PKClambda and PKCzeta , are not activated by diacylglycerol or phorbol ester, whereas members of the other two classes, conventional PKC and novel PKC, are activated by these reagents both in vitro and in vivo (1, 2, 36-38, 40, 49). PKCiota , also identified as an atypical PKC isozyme, is the human counterpart of mouse PKClambda (42). Evidence suggests that atypical PKC is the second type of serine-threonine kinase that acts downstream of PI 3-kinase. PKCzeta is activated in vitro by phosphatidylinositol 3,4,5-trisphosphate (36), another product of PI 3-kinase activity (46). When expressed in 3Y1 fibroblasts or HepG2 hepatoma cells expressing various mutant platelet-derived growth factor receptors, PKClambda contributed to trans activation of the tetradecanoyl phorbol acetate-responsive element in response to platelet-derived growth factor or epidermal growth factor in a PI 3-kinase-dependent manner (2). Furthermore, the activity of atypical PKC stimulated by either insulin or bacterial lipopolysaccharide was shown to be inhibited by either a pharmacological inhibitor or a dominant negative mutant of PI 3-kinase (22, 34, 43). All of these observations indicate that atypical PKC isozymes are downstream effectors of PI 3-kinase.

Stimulation of glucose uptake into skeletal muscle and adipocytes is one of the most important actions of insulin. Insulin-stimulated glucose uptake and translocation of the glucose transporter GLUT4 to the plasma membrane, an essential step for glucose uptake in muscle and adipocytes, were markedly attenuated by pharmacological inhibitors or a dominant negative mutant of PI 3-kinase (13, 39, 41). Furthermore, a constitutively active mutant of PI 3-kinase promoted glucose uptake and translocation of GLUT4 in quiescent adipocytes (20). These observations suggest a central role for PI 3-kinase in regulation of glucose transport. However, a downstream effector of PI 3-kinase that mediates stimulation of glucose uptake has not been identified.

Although Akt and atypical PKC act downstream of PI 3-kinase, it remains unclear which actions of PI 3-kinase are mediated by which protein kinase. It is also not known whether Akt and atypical PKC act in the same signaling pathway or whether they transmit signals through different pathways. To address these important questions, we have investigated the roles of these protein kinases in insulin-stimulated glucose uptake. We recently showed that a mutant Akt in which the sites of ligand-induced phosphorylation were replaced by alanine acts in a dominant negative manner (26). Because this mutant did not affect insulin-induced glucose uptake (26), we have now examined the possible role of atypical PKC as a downstream effector of PI 3-kinase in this process. We have investigated the effects of dominant negative mutants and a constitutively active mutant of PKClambda in order to determine whether this enzyme participates in the regulation of glucose uptake by insulin in 3T3-L1 adipocytes. We have also investigated whether Akt and PKClambda function in the same or different signaling pathways.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Cells and antibodies. 3T3-L1 preadipocytes were maintained and induced to differentiate into adipocytes as described previously (41). To establish CHO-IR cells that express (in addition to human insulin receptors) tagged PKClambda (CHO-IR/PKClambda cells), we transfected CHO-IR cells with both pSV40-high (which confers resistance to hygromycin) and an SRD vector encoding T7 epitope-tagged mouse PKClambda (2). Transfected cells were selected and cloned as described previously (25). CHO cells that express FLAG epitope-tagged Akt (CHO-Akt cells) have been described previously (26). To prepare a construct encoding mouse PKCzeta tagged with the T7 epitope, we performed PCR with a sense primer (5'-AAG GCC ATG GCT AGC ATG ACT GGT GGA CAG CAA ATG GGT CCC AGC AGG ACC GAC), an antisense primer (5'-GAG GTC GAA GTC TTG CAG CCC), and a full-length mouse PKCzeta cDNA as the template. The resulting PCR product, containing nucleotides 4 to 762 of PKCzeta cDNA fused with a DNA sequence encoding the T7 epitope, was digested with PstI and ligated to the PstI site of cDNA encoding mouse PKCzeta . The resulting cDNA construct encoded T7 epitope-tagged mouse PKCzeta and was subcloned into an SRalpha expression vector.

Polyclonal antibodies to PKClambda (alpha lambda 190) and to PKCzeta (alpha zeta 170) were generated against glutathione S-transferase (GST) fusion proteins containing amino acids 190 to 240 of mouse PKClambda or amino acids 170 to 240 of mouse PKCzeta , respectively. A monoclonal antibody (MAb) to PKClambda (alpha lambda CT), induced by a GST fusion protein containing amino acids 397 to 558 of mouse PKClambda , was obtained from Transduction Laboratories. Polyclonal antibodies to PKCzeta (alpha zeta CT), generated in response to a peptide corresponding to the COOH terminus of rat PKCzeta (amino acids 577 to 592), were obtained from GIBCO BRL. Polyclonal antibodies to PKClambda (alpha lambda 197) that were generated in response to a peptide corresponding to amino acids 197 to 213 of mouse PKClambda were as described previously (1). Polyclonal antibodies to Akt, induced by a GST fusion protein containing amino acids 428 to 480 of rat Akt1, as well as a MAb (1F8) and polyclonal antibodies to GLUT4 were as described previously (41). Antibodies to Akt2 and to Akt3 were obtained from Upstate Biotechnology.

RT-PCR. Transcripts encoding PKClambda or PKCzeta were detected by reverse transcription (RT)-PCR analysis. Complementary DNA was synthesized, with the use of a FastTrack 2.0 kit and a cDNA Cycle kit (Invitrogen), from ~300 µg of polyadenylated RNA extracted from 3T3-L1 adipocytes or total RNA extracted from mouse brain. PCR was then performed with 1/10 of the resulting cDNA as the template and with primers that correspond to nucleotides 247 to 265 and 576 to 595 of mouse PKClambda cDNA or to nucleotides 145 to 164 and 700 to 719 of mouse PKCzeta cDNA. The amplification protocol comprised 30 cycles of denaturation at 94°C for 1 min, annealing at 50°C for 1 min, and extension at 72°C for 1 min.

Construction of and infection with adenovirus vectors. Various PKClambda mutant constructs are shown in Fig. 1. Complementary DNAs encoding wild-type mouse PKClambda (lambda WT) and a kinase-deficient mutant in which glutamate is substituted for Lys273 in the kinase domain (lambda KD) were as described previously (2). To prepare constructs encoding lambda Delta PD and lambda Delta PDKD, hemagglutinin (HA) epitope-tagged, NH2-terminal-deletion mutants of PKClambda , we performed PCR with sense (5'-TTA GGT ACC ATG TAC CCA TAC GAT GTT CCG GAT TAC GCT AGC CTC GCC AAA CGT TTC AAT AGG CGC) and antisense (5'-GAT ACC ACT CTC CCT GGT) primers and wild-type mouse PKClambda cDNA as a template. The resulting PCR product, containing nucleotides 442 to 735 of PKClambda cDNA fused with a DNA sequence encoding the HA epitope, was digested with EcoT22I and ligated to the EcoT22I site of cDNA encoding either lambda WT or lambda KD. To construct lambda Delta NKD, we performed PCR with sense (5'-TTA GGT ACC ATG TAC CCA TAC GAT GTT CCG GAT TAC GCT AGC CTC TCG TCC AGT CTA GGT CTG CAG) and antisense (5'-GAT AGA ATG CAG CCC GAC) primers and lambda KD cDNA as a template. The resulting product, containing nucleotides 742 to 966 of PKClambda cDNA fused with a DNA sequence encoding the HA epitope, was digested with ClaI and fused with the ClaI site of cDNA encoding lambda WT. Complementary DNA encoding the wild-type or various mutant proteins was subcloned into pAxCAwt (35), and adenovirus vectors containing these cDNAs were generated by transfecting 293 cells with the corresponding pAxCAwt plasmid together with DNA-terminal protein complex (35), as described previously (41). The resulting vectors were termed AxCAlambda WT, AxCAlambda KD, AxCAlambda Delta PD, AxCAlambda Delta PDKD, and AxCAlambda Delta NKD, respectively.


View larger version (27K):
[in this window]
[in a new window]
  		FIG. 1.   Structures of various mutants of PKClambda , lambda KD, lambda Delta NKD, and lambda Delta PDKD contain a Lys273-to-Glu mutation (K273E). lambda Delta PD, lambda Delta PDKD, and lambda Delta NKD contain the HA epitope at their truncated NH2 termini. The first and last amino acids of each protein are numbered. PD, CR, and CD, pseudosubstrate, cysteine-rich, and catalytic domains, respectively.

An adenovirus vector encoding a dominant negative mutant of PI 3-kinase (AxCADelta p85) was as described previously (41). An adenovirus vector encoding a mutant Akt (AxCAAkt-AA) in which the phosphorylation sites (Thr308 and Ser473) targeted by growth factors are replaced by alanine was as previously described (26). CHO cells or 3T3-L1 adipocytes were infected with adenovirus vectors at the multiplicities of infection (MOIs) (in PFU per cell) indicated in Results, as described previously (41, 50). The cells were used in experiments 24 to 48 h after infection.

After we submitted this paper, the wild-type mouse PKClambda cDNA used to construct the adenoviruses encoding the various mutant proteins was found to lack the nucleotides encoding the 47 NH2-terminal amino acids. Although the deleted amino acid sequence does not contain any known functional domains, we repeated all of the experiments that used the NH2-terminally deleted lambda WT or lambda KD with adenovirus vectors encoding a full-length wild-type or a full-length kinase-deficient PKClambda , and we obtained essentially identical results. This further suggests that the NH2-terminal 47 amino acids are not essential for the signaling of insulin-induced glucose uptake.

Kinase assays. CHO cells or 3T3-L1 adipocytes were deprived of serum for 16 to 20 h, incubated in the absence or presence of insulin, and then immediately frozen with liquid nitrogen. For assay of the kinase activity of endogenous or T7 epitope-tagged PKClambda , the frozen cells were lysed as described previously (2) and the lysate was centrifuged (15,000 × g for 20 min). The protein concentration in the resulting supernatants was determined with the use of the bicinchoninic acid protein assay reagent (Pierce), and equal amounts of protein were subjected to immunoprecipitation with polyclonal antibodies or MAbs to PKClambda or with antibodies to the T7 epitope tag. After washing twice with buffer A (50 mM MOPS [morpholinepropanesulfonic acid]-HCl [pH 7.5], 0.5% Triton X-100, 10% glycerol, 0.1% bovine serum albumin, 5 mM EDTA, 5 mM EGTA, 20 mM NaF, 50 mM beta -glycerophosphate, 2 mM sodium orthovanadate, 2 mM dithiothreitol, 1 µg of leupeptin per ml, and 2 mM phenylmethylsulfonyl fluoride), once with buffer A containing 1 M NaCl, and then once with a solution containing 20 mM Tris-HCl (pH 7.5), 5 mM MgCl2, and 1 mM EGTA, the immunoprecipitates were incubated for 14 min at 30°C with 0.4 µCi of [gamma -32P]ATP in a reaction mixture (25 µl) containing 35 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 0.5 mM EGTA, 0.1 mM CaCl2, 40 µM unlabeled ATP, and 30 µM myelin basic protein (MBP) as a substrate. When indicated, phosphatidylserine (PS) (100 µg/ml) was also present in the reaction mixture.

For assay of the kinase activity of endogenous or FLAG-tagged Akt, the frozen cells were lysed in a solution containing 50 mM HEPES-NaOH (pH 7.6), 150 mM NaCl, 1% Triton X-100, 1 mg of bacitracin per ml, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM sodium orthovanadate, 10 mM NaF, and 30 mM sodium pyrophosphate. The lysates were subjected to immunoprecipitation with antibodies to Akt or to FLAG. After three washes with HEPES-buffered saline (pH 7.5) containing 0.1% Triton X-100, the immunoprecipitates were incubated for 30 min at 30°C with 3.0 µCi of [gamma -32P]ATP in a reaction mixture (30 µl) containing 20 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 25 µM unlabeled ATP, 1 µM protein kinase inhibitor, and 0.2 mg of histone 2B per ml as a substrate.

All kinase reactions were terminated by the addition of sodium dodecyl sulfate (SDS) sample buffer, and the samples were then fractionated by SDS-polyacrylamide gel electrophoresis. The radioactivity incorporated into substrates was determined with a Fuji BAS 2000 image analyzer.

Glucose uptake and translocation of GLUT4. Glucose uptake was assayed as described previously (41). In brief, 3T3-L1 adipocytes were incubated for 16 h in Dulbecco's modified Eagle's medium containing 5.6 mM glucose and 0.5% fetal bovine serum. The cells were washed twice with DB buffer (140 mM NaCl, 2.7 mM KCl, 1 mM CaCl2, 1.5 mM KH2PO4, 8 mM Na2HPO4 [pH 7.4], 0.5 mM MgCl2) and then incubated with 100 nM insulin for 15 min, 0.5 µg of growth hormone (GH) per ml for 10 min, or 300 mM sorbitol for 60 min. DB buffer (1 ml) containing bovine serum albumin (1 mg/ml) and 0.1 mM 2-deoxy-D-[1,2-3H]glucose (1 µCi) was added to each well, and after 5 min, the cells were washed and then solublized with 0.1% SDS. The radioactivity incorporated into the cells was measured with a liquid scintillation counter.

Translocation of GLUT4 to the plasma membrane was measured by the plasma membrane lawn assay as previously described (41). In brief, 3T3-L1 adipocytes cultured on coverslips were incubated in a hypotonic buffer and immediately disrupted by being placed under an ultrasonic microprobe. For antibody labeling, sonicated cells were fixed in 2% paraformaldehyde, and the lawn of plasma membrane fragments was prepared with antibodies to GLUT4 and tetramethyl rhodamine isothiocyanate-labeled secondary antibodies. Samples were then examined with a fluorescence microscope.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Expression of PKClambda in 3T3-L1 adipocytes. Atypical PKC isozymes comprise PKClambda and PKCzeta . To examine the relative abundances of these two isoforms in 3T3-L1 adipocytes, we prepared antibodies specific for each. T7 epitope-tagged PKClambda or PKCzeta was transiently expressed in COS7 cells, and cell lysates were subjected to immunoprecipitation with antibodies either to PKClambda (alpha lambda 190), to PKCzeta (alpha zeta 170), or to the T7 epitope or with control serum. The immunoprecipitates were then subjected to immunoblot analysis with antibodies to T7 (Fig. 2A). Proteins of ~80 kDa reactive with antibodies to T7 were detected in the immunoprecipitates prepared from the lysates expressing T7-tagged PKClambda with alpha lambda 190 or with antibodies to T7 and in the immunoprecipitates prepared from the lysates expressing T7-tagged PKCzeta with alpha zeta 170 or with antibodies to T7. These results indicate that alpha lambda 190 and alpha zeta 170 specifically recognize PKClambda and PKCzeta , respectively. In contrast, polyclonal antibodies generated against a peptide corresponding to the COOH terminus of rat PKCzeta (alpha zeta CT) detected both T7-tagged PKClambda and PKCzeta (Fig. 2B), indicating that these antibodies recognize both PKClambda and PKCzeta .


View larger version (49K):
[in this window]
[in a new window]
  		FIG. 2.   Expression of PKClambda , but not PKCzeta , in 3T3-L1 adipocytes. (A) Specificity of antibodies to PKClambda and PKCzeta . COS7 cells cultured in 6-cm-diameter dishes were transiently transfected, with the use of Lipofectamine (Gibco), with 6 µg of SRD or SRalpha vectors encoding T7 epitope-tagged PKClambda or PKCzeta . Cell lysates were subjected to immunoprecipitation (IP) with antibodies to T7, to PKClambda (alpha lambda 190), or to PKCzeta (alpha zeta 170) or with control serum (Cont), and the resulting immunoprecipitates were subjected to immunoblot analysis with antibodies to T7. (B) Recognition of both PKClambda and PKCzeta by antibodies generated in response to a peptide corresponding to the COOH terminus of rat PKCzeta (alpha zeta CT). COS7 cells transiently transfected as described for panel A were lysed and subjected to immunoprecipitation with either antibodies to T7 or normal mouse globulin (NMG). The resulting immunoprecipitates were then subjected to immunoblot analysis with either antibodies to T7 (lower panel) or alpha zeta CT (upper panel). (C) Analysis of PKClambda and PKCzeta protein expression in mouse brain and 3T3-L1 adipocytes. Lysates prepared from mouse brain or 3T3-L1 adipocytes were subjected to immunoprecipitation with alpha lambda 190, alpha zeta 170, or control rabbit serum, and the immunoprecipitates were subjected to immunoblot analysis with alpha zeta CT. (D) Analysis of PKClambda and PKCzeta transcripts in mouse brain and 3T3-L1 adipocytes. PCR was performed with primers specific for mouse PKClambda or PKCzeta cDNA and with either the indicated concentration of full-length PKClambda or PKCzeta cDNA subcloned into the SRD vector (left panel) or cDNA synthesized from RNA extracted from either mouse brain or 3T3-L1 adipocytes (right panel). Amplification products were analyzed by agarose gel electrophoresis and ethidium bromide staining. Lane M, molecular size standards. Data are representative of those from three experiments.

When a cell lysate prepared from mouse brain was subjected to immunoprecipitation with either alpha lambda 190, alpha zeta 170, or control serum and the immunoprecipitates were then subjected to immunoblot analysis with alpha zeta CT, proteins of ~80 kDa were detected in the immunoprecipitates prepared with alpha lambda 190 or alpha zeta 170 but not in those prepared with control serum, suggesting that brain expresses both PKClambda and PKCzeta (Fig. 2C). In contrast, when 3T3-L1 adipocyte lysates were subjected to the same analysis, an ~80-kDa protein was detected only in the immunoprecipitate prepared with alpha lambda 190 (Fig. 2C). When the same membrane was probed with a MAb generated in response to a GST fusion protein containing amino acids 397 to 558 of mouse PKClambda (alpha lambda CT), again an ~80-kDa protein was detected only in the immunoprecipitate prepared with alpha lambda 190 (data not shown). These results suggest that 3T3-L1 adipocytes express PKClambda protein but not PKCzeta protein.

We also examined the expression of PKClambda and PKCzeta at the mRNA level by RT-PCR. PCR performed with specific oligonucleotide primers based on the sequence of either mouse PKClambda or PKCzeta cDNA, and with as little as 0.6 pM PKClambda or PKCzeta cDNA subcloned into the SRD vector as a template, yielded amplification products of the expected size (~350 bp for PKClambda and ~570 bp for PKCzeta ) (Fig. 2D). When PCR was performed with the same primer pairs and cDNA that was synthesized from RNA extracted from mouse brain, PCR products of the expected size were obtained with each set of primers. However, with cDNA that was synthesized from RNA extracted from 3T3-L1 adipocytes as the template, a PCR product of the expected size was obtained with the primers corresponding to PKClambda but not with those corresponding to PKCzeta . Thus, consistent with the results of protein analysis, 3T3-L1 adipocytes contain PKClambda mRNA but not PKCzeta mRNA.

Activation of PKClambda by insulin in a PI 3-kinase-dependent manner. 3T3-L1 adipocytes were incubated for various times in the absence or presence of 100 nM insulin, lysed, and subjected to immunoprecipitation with control serum or polyclonal antibodies to PKClambda generated against a peptide corresponding to amino acids 197 to 213 of mouse PKClambda (alpha lambda 197). These antibodies were previously shown not to cross-react with PKCzeta (1). Kinase activity in the immunoprecipitates was then assayed with MBP as a substrate. The kinase activity precipitated by alpha lambda 197 was markedly greater than that precipitated by control serum (Fig. 3B). Activation of PKClambda was evident within 3 min of exposure of cells to insulin; the activity was maximal (about three times that of the basal value) at 5 min and remained increased at 10 min (Fig. 3A). Prior treatment of the cells with 100 nM wortmannin or infection of the cells with AxCADelta p85, an adenovirus vector that encodes a dominant negative mutant of PI 3-kinase (41), prevented insulin-induced activation of PKClambda (Fig. 3B).


View larger version (36K):
[in this window]
[in a new window]
  		FIG. 3.   Stimulation of PKClambda activity by insulin in 3T3-L1 and CHO cells. (A) Time course of insulin stimulation of PKClambda activity in 3T3-L1 adipocytes. 3T3-L1 cells cultured in 6-cm-diameter plates were incubated in the presence of 100 nM insulin for the indicated times, after which the cells were lysed and subjected to immunoprecipitation with polyclonal antibodies to PKClambda (alpha lambda 197). The resulting immunoprecipitates were then assayed for kinase activity with MBP as a substrate. Data are expressed relative to the activity at zero time. (B) Effects of inhibitors of PI 3-kinase on insulin stimulation of PKClambda activity in 3T3-L1 adipocytes. 3T3-L1 cells were incubated in the absence or presence of 100 nM wortmannin for 20 min or were infected at the indicated MOI (PFU per cell) with an adenovirus vector encoding Delta p85 (AxCADelta p85), and they were then incubated in the absence or presence of 100 nM insulin for 5 min. Cells were then lysed and subjected to immunoprecipitation (IP) with either alpha lambda 197 or normal rabbit serum (NRS). Immunoprecipitates were assayed for PKClambda activity as described for panel A. Data are expressed relative to the activity of control alpha lambda 197 precipitates. (C) Insulin stimulation of PKClambda activity in transiently transfected CHO-IR cells. CHO-IR cells were transiently transfected with constructs encoding T7-tagged wild-type PKClambda or lambda KD. After 48 h, the cells were deprived of serum, incubated in the absence or presence of 100 nM insulin for 3 min, and then lysed. The lysates were subjected to immunoprecipitation with antibodies to T7, and the immunoprecipitates were subjected either to immunoblot analysis with antibodies to T7 (upper panel) or to the PKClambda kinase assay (lower two panels). (D) Effect of Delta p85 on insulin-stimulated PKClambda activity in CHO-IR/PKClambda cells. CHO-IR/PKClambda cells were infected with AxCADelta p85 at the indicated MOI (PFU per cell). Cells were then incubated in the absence or presence of 100 nM insulin for 3 min, after which cell lysates were subjected to immunoprecipitation with antibodies to the T7 epitope and PKClambda activity was assayed in the resulting precipitates. Data are expressed relative to the activity of precipitates from uninfected cells not exposed to insulin. Quantitative data in panels A, B, and D are means ± standard errors from three experiments, and those in panel C are means from two experiments.

To confirm that insulin activates PKClambda , we transiently transfected CHO-IR cells with constructs encoding T7 epitope-tagged wild-type PKClambda or a mutant PKClambda in which Lys273 in the kinase domain was replaced by glutamate (lambda KD). The transfected cells were incubated in the absence or presence of insulin, lysed, and subjected to immunoprecipitation with antibodies to T7. Although the amounts of T7-tagged PKClambda and lambda KD in the immunoprecipitates were similar, the precipitates prepared from the cells expressing PKClambda showed higher kinase activity, and this activity was increased about 1.8-fold in response to insulin (Fig. 3C). These observations suggest that the kinase activity precipitated with antibodies to T7 was attributable to PKClambda and not to some other kinase associated with PKClambda .

To investigate further the effect of insulin on PKClambda activation, we established a CHO cell line that stably expresses both human insulin receptors and T7 epitope-tagged mouse PKClambda (CHO-IR/PKClambda cells). Exposure of CHO-IR/PKClambda cells to insulin for 3 min resulted in an ~2.5-fold increase in PKClambda activity measured in immunoprecipitates prepared with antibodies to the T7 epitope (Fig. 3D). This stimulation was inhibited by infection of cells with AxCADelta p85. These results suggested that PKClambda is activated by insulin in a PI 3-kinase-dependent manner.

Dominant negative effects of kinase-defective mutants of PKClambda on insulin-induced activation of PKClambda . To investigate the roles of PKClambda in cells by specifically inhibiting the activity of the endogenous enzyme, we have constructed adenovirus vectors that encode dominant negative mutants of PKClambda . Infection of cells with an adenovirus (AxCAlambda KD) encoding lambda KD revealed that the mutant enzyme was not activated either by insulin treatment in intact cells (Fig. 4A) or by addition of PS to the kinase assay mixture (Fig. 4B); PS stimulated the activity of the wild-type enzyme ~2.5-fold. Infection of CHO-IR/PKClambda cells with AxCAlambda KD resulted in inhibition of insulin-induced activation of PKClambda (measured in immunoprecipitates prepared with antibodies to the T7 epitope) in an MOI-dependent manner (Fig. 5A), without an effect on the amount of T7 epitope-tagged PKClambda in the cells (data not shown).


View larger version (22K):
[in this window]
[in a new window]
  		FIG. 4.   Effects of insulin in vivo and PS in vitro on the kinase activities of various PKClambda mutants. (A) 3T3-L1 adipocytes cultured in six-well plates were infected (or not) with adenovirus vectors encoding lambda Delta PD (Delta PD), lambda KD (KD), or lambda Delta NKD (Delta NKD) at an MOI of 150, 30, or 50 PFU/cell, respectively. The cells were then incubated in the absence or presence of 100 nM insulin for 5 min, lysed, and subjected to immunoprecipitation with a MAb to PKClambda . The immunoprecipitates were assayed for PKClambda activity. (B) KB cells cultured in six-well plates were infected (or not) with adenovirus vectors encoding lambda WT (WT), lambda KD (KD), lambda Delta PD (Delta PD), or lambda Delta NKD (Delta NKD) at an MOI of 1, 3, 15, or 5 PFU/cell, respectively; these MOIs resulted in the expression of similar amounts of PKClambda proteins. The cells were lysed, the total lysates were subjected to immunoprecipitation with a MAb to PKClambda , and the immunoprecipitates were assayed for PKClambda activity in the absence or presence of PS (100 µg/ml). Data are means ± standard errors from three experiments.


View larger version (42K):
[in this window]
[in a new window]
  		FIG. 5.   Effects of lambda KD and lambda Delta NKD on insulin-induced activation of PKClambda . (A and B) CHO-IR/PKClambda cells were infected with AxCAlambda KD (A) or AxCAlambda Delta NKD (B) at the indicated MOI (PFU per cell), incubated in the absence or presence of 100 nM insulin for 5 min, and lysed. The total lysates were subjected to immunoprecipitation with a MAb to the T7 epitope, and the immunoprecipitates were then assayed for PKClambda activity. (C) 3T3-L1 adipocytes were infected with AxCAlambda Delta NKD at the indicated MOI (PFU per cell), incubated in the absence or presence of 100 nM insulin for 5 min, and lysed. The total lysates were subjected to immunoblot analysis with a MAb to PKClambda (lower panel) or to immunoprecipitation with polyclonal antibodies to PKClambda (alpha lambda 197); the immunoprecipitates were then assayed for PKClambda activity (upper panel). Quantitative data are expressed as fold stimulation relative to uninfected cells not exposed to insulin and are means ± standard errors from three experiments.

Although these results indicated that lambda KD inhibits the activation of transfected PKClambda by insulin, we could not examine the effect of this mutant on endogenous PKClambda activity because the polyclonal antibodies to PKClambda (alpha lambda 197) also precipitate lambda KD. We therefore constructed an adenovirus vector (AxCAlambda Delta NKD) that encodes an NH2-terminally truncated version of lambda KD (lambda Delta NKD); because this mutant does not possess the region of PKClambda corresponding to the immunogen, it is not recognized by the polyclonal antibodies to PKClambda . lambda Delta NKD was not activated either by insulin in vivo or by PS in vitro (Fig. 4). Infection of CHO-IR/PKClambda cells with AxCAlambda Delta NKD resulted in an MOI-dependent inhibition of insulin-induced activation of T7 epitope-tagged PKClambda (Fig. 5B). The extent of the inhibition paralleled the extent of expression of the mutant protein, and the expression of the mutant protein did not affect the amount of T7 epitope-tagged PKClambda (data not shown).

We then investigated the effect of lambda Delta NKD on endogenous PKClambda activity in 3T3-L1 adipocytes. Fully differentiated 3T3-L1 adipocytes were infected with AxCAlambda Delta NKD at various MOIs and incubated in the absence or presence of insulin, after which immunoprecipitates prepared with polyclonal antibodies to PKClambda were assayed for PKClambda activity. Insulin stimulation of endogenous PKClambda activity in 3T3-L1 adipocytes was inhibited by lambda Delta NKD in an MOI-dependent manner, being virtually abolished at an MOI of 100 PFU/cell (Fig. 5C); again, the extent of inhibition paralleled the extent of expression of the mutant protein, and the expression of the mutant protein did not affect the amount of endogenous PKClambda protein (Fig. 5C). Immunoblot analysis revealed that the amount of mutant PKClambda protein in the cells infected with AxCAlambda Delta NKD at an MOI of 100 PFU/cell was 5 to 10 times that of endogenous PKClambda protein. Insulin-induced stimulation of PI 3-kinase activity in 3T3-L1 cells, measured in immunoprecipitates prepared with antibodies to phosphotyrosine, was not inhibited by either lambda KD or lambda Delta NKD (data not shown). Thus, both of these PKClambda mutants exerted dominant negative effects on insulin-induced activation of PKClambda .

Inhibition of insulin-stimulated glucose uptake and GLUT4 translocation by dominant negative mutants of PKClambda . We next examined the effects of the dominant negative mutants of PKClambda on insulin-stimulated glucose uptake and translocation of GLUT4 in 3T3-L1 adipocytes. Cells were infected with either AxCAlambda KD or AxCAlambda Delta NKD and then assayed for insulin-induced glucose uptake. Overexpression of either lambda KD or lambda Delta NKD resulted in a dose-dependent inhibition of insulin-stimulated glucose uptake (Fig. 6A and B). Basal glucose transport was not affected by infection of cells with the viruses encoding either of the dominant negative mutants of PKClambda (Fig. 6A and B). The amounts of GLUT4 protein, assessed by immunoblot analysis, in infected and noninfected cells were also similar (Fig. 7). Glucose uptake stimulated by either GH or hyperosmolarity (300 mM sorbitol) was not affected by AxCAlambda KD (Fig. 6C).


View larger version (21K):
[in this window]
[in a new window]
  		FIG. 6.   Effects of lambda KD and lambda Delta NKD on glucose uptake in 3T3-L1 adipocytes. (A and B) 3T3-L1 adipocytes were infected with AxCAlambda KD (A) or AxCAlambda Delta NKD (B) at the indicated MOI (PFU per cell) and then incubated in the absence or presence of 100 nM insulin for 15 min. Cells were then assayed for glucose uptake. (C) 3T3-L1 adipocytes were infected (or not) with AxCAlambda KD at an MOI of 150 PFU/cell, incubated in the absence or presence of GH (0.5 µg/ml) for 10 min or 300 mM sorbitol for 60 min, and then assayed for glucose uptake. Data are means ± standard errors from three experiments.


View larger version (30K):
[in this window]
[in a new window]
  		FIG. 7.   Effects of various PKClambda mutants on the amount of GLUT4 protein in 3T3-L1 adipocytes. Cells were infected (or not) with AxCAlambda KD, AxCAlambda Delta PD, AxCAlambda Delta NKD, or AxCAlambda WT at an MOI of 150 PFU/cell, and total cell lysates were subjected to immunoprecipitation with a MAb to GLUT4. The immunoprecipitates were then subjected to immunoblot analysis with polyclonal antibodies to GLUT4.

To confirm that the observed inhibition of insulin-induced glucose uptake was due to inhibition of PKClambda activity, we attempted to reverse the effect of the lambda Delta NKD mutant by overexpressing the wild-type enzyme. 3T3-L1 adipocytes were infected first with AxCAlambda Delta NKD at an MOI of 100 PFU/cell, and, after 12 h, they were infected again with AxCAlambda WT, an adenovirus vector encoding wild-type PKClambda , at different MOIs (Fig. 8). The cells were then assayed for insulin-induced glucose uptake. Infection of the cells with AxCAlambda WT partially reversed the inhibition of glucose uptake by lambda Delta NKD in an MOI-dependent manner. The expression of lambda Delta NKD protein was not affected by the second infection of the cells with AxCAlambda WT (data not shown). These results suggested that the inhibition of insulin-induced glucose uptake by lambda Delta NKD is due to inhibition of PKClambda activity.


View larger version (36K):
[in this window]
[in a new window]
  		FIG. 8.   Effect of overexpression of wild-type PKClambda on the inhibition of insulin-stimulated glucose uptake by lambda Delta NKD. 3T3-L1 adipocytes were infected (or not) with AxCAlambda Delta NKD at an MOI of 100 PFU/cell and, after 12 h, with AxCAlambda WT at the indicated MOI. After an additional 36 h, the cells were assayed for glucose uptake. Data are means ± standard errors from three experiments.

The effects of the dominant negative mutants of PKClambda on insulin-stimulated translocation of GLUT4 were examined by the plasma membrane lawn assay. Exposure of noninfected 3T3-L1 adipocytes to insulin resulted in a marked increase in the amount of GLUT4 immunoreactivity in the plasma membrane, an effect that was substantially inhibited in cells infected with AxCAlambda KD (Fig. 9). An essentially identical inhibitory effect on insulin-induced translocation of GLUT4 was observed in cells infected with AxCAlambda Delta NKD (data not shown). These results suggested that PKClambda activity is required for insulin-induced glucose uptake and translocation of GLUT4.


View larger version (74K):
[in this window]
[in a new window]
  		FIG. 9.   Effects of PKClambda mutants on translocation of GLUT4 to the plasma membrane of 3T3-L1 adipocytes. Uninfected cells (A and B) or cells that were infected with AxCAlambda KD (C) or AxCAlambda Delta PD (D through F) at an MOI of 150 PFU/cell were incubated in the absence (A through E) or presence (F) of 100 nM wortmannin for 20 min and then in the absence (A, D, and F) or presence (B, C, and E) of 100 nM insulin for 5 min. Plasma membrane fragments were then prepared for immunofluorescence microscopy with antibodies to GLUT4 and tetramethyl rhodamine isothiocyanate-labeled secondary antibodies. Data are representative of those from at least three independent experiments.

Enhancement of glucose transport and GLUT4 translocation by a constitutively active mutant of PKClambda . To investigate whether activation of PKClambda is capable of stimulating glucose uptake in 3T3-L1 adipocytes, we prepared an adenovirus vector that encodes a constitutively active mutant of PKClambda . Because the activity of PKC enzymes is negatively regulated by the pseudosubstrate domain, we constructed a mutant PKClambda that lacks this domain (lambda Delta PD). As expected, the kinase activity of lambda Delta PD was markedly greater than that of the wild-type enzyme, and this activity was little affected by insulin treatment in vivo or PS in vitro (Fig. 4). Infection of 3T3-L1 adipocytes with a virus (AxCAlambda Delta PD) that encodes this mutant resulted in stimulation of glucose uptake in an MOI-dependent manner (Fig. 10). The extent of the stimulation paralleled the extent of expression of the mutant protein (data not shown). At an MOI of 150 PFU/cell, the extent of the stimulatory effect was similar to that achieved by 100 nM insulin (Fig. 10). lambda Delta PDKD, a mutant PKClambda that lacks both kinase activity and the pseudosubstrate domain, did not stimulate glucose uptake (data not shown), suggesting that the activation of sugar transport by lambda Delta PD was due to its kinase activity and not to nonspecific effects of viral infection. Furthermore, the amounts of GLUT4 (Fig. 7) and of insulin-stimulated PI 3-kinase activity precipitated with antibodies to phosphotyrosine (data not shown) were not increased by expression of lambda Delta PD. Insulin did not increase glucose uptake further in cells that had been infected with AxCAlambda Delta PD at an MOI of 150 PFU/cell, and treatment of such cells with wortmannin had little effect on glucose uptake (Fig. 10). Moreover, GLUT4 translocation, as assessed by the plasma membrane lawn assay, was stimulated by lambda Delta PD, and this stimulation was not affected by insulin or wortmannin (Fig. 9).


View larger version (36K):
[in this window]
[in a new window]
  		FIG. 10.   Effect of lambda Delta PD on glucose uptake in 3T3-L1 adipocytes. Cells were infected with AxCAlambda Delta PD at the indicated MOI (PFU per cell) and incubated in the absence or presence of 100 nM wortmannin for 20 min and then with or without 100 nM insulin for 10 min. Glucose uptake was then assayed. Data are means ± standard errors from three experiments.

Localization of PKClambda and Akt to different signaling pathways. Finally, we examined whether PKClambda and Akt, both of which are downstream effectors of PI 3-kinase, act in the same or different signaling pathways. Insulin induced a fivefold increase in Akt activity in 3T3-L1 adipocytes (Fig. 11A). Infection of cells with AxCAlambda KD did not affect insulin-induced activation of Akt, even at an MOI of 150 PFU/cell, a dose sufficient to inhibit insulin-induced glucose uptake by ~50% (Fig. 6A). Infection with AxCAlambda Delta PD did not result in the activation of Akt, even at an MOI of 150 PFU/cell (Fig. 11B), a virus dose sufficient to activate glucose uptake to an extent similar to that achieved by insulin (Fig. 10). Essentially similar results were obtained with CHO cells (data not shown). These observations indicate that Akt does not function downstream of PKClambda .


View larger version (27K):
[in this window]
[in a new window]
 

View larger version (29K):
[in this window]
[in a new window]
 

View larger version (26K):
[in this window]
[in a new window]
  		FIG. 11.   Localization of PKClambda and Akt to different signaling pathways. (A and B) Effects of lambda KD (A) and lambda Delta PD (B) on Akt activity in 3T3-L1 adipocytes. Cells were infected with AxCAlambda KD (A) or AxCAlambda Delta PD (B) at the indicated MOI (PFU per cell) and then incubated in the absence or presence of 100 nM insulin for 10 min. Cell lysates were subjected to immunoprecipitation with antibodies to Akt, and the resulting precipitates were assayed for Akt kinase activity. (C and D) Effects of a dominant negative mutant of Akt on insulin-induced activation of Akt (C) and PKClambda (D) in CHO-Akt cells. Cells were infected at the indicated MOI (PFU per cell) with an adenovirus vector (AxCAAkt-AA) encoding Akt-AA, incubated in the absence or presence of 100 nM insulin for 10 min, and lysed. Lysates were subjected to immunoprecipitation with antibodies to either the FLAG epitope (C) or PKClambda (D), and the resulting immunoprecipitates were assayed for Akt or PKClambda activity, respectively. (E and F) Effects of Akt-AA on insulin-induced activation of Akt2 (E) and PKClambda (F) in 3T3-L1 adipocytes. Cells were infected with AxCAAkt-AA at the indicated MOI (PFU/cell), incubated in the absence or presence of 100 nM insulin for 3 min, and lysed. Lysates were subjected to immunoprecipitation with antibodies to Akt2 (E) or to PKClambda (F), and the precipitates were assayed for Akt and PKClambda activity, respectively. Data are means ± standard errors from three experiments.

We next investigated whether Akt contributes to the activation of PKClambda with the use of a dominant negative mutant of Akt. We have recently shown that a mutant Akt (Akt-AA) in which the phosphorylation sites (Thr308 and Ser473) targeted by growth factors are replaced by alanine acts in a dominant negative manner (26). Infection of CHO cells stably expressing FLAG epitope-tagged rat Akt1 (CHO-Akt cells) with an adenovirus encoding Akt-AA (AxCAAkt-AA) resulted in inhibition of insulin-stimulated Akt activity in an MOI-dependent manner; at an MOI of 20 PFU/cell, ~70% inhibition was achieved (Fig. 11C). Insulin treatment of CHO-Akt cells increased twofold the kinase activity measured in immunoprecipitates prepared with antibodies to PKClambda , and this stimulatory action of insulin on PKClambda activity was not affected by expression of Akt-AA (Fig. 11D).

We also tested the effect of Akt-AA on insulin stimulation of PKClambda activity in 3T3-L1 adipocytes. We have previously shown that infection of these cells with AxCAAkt-AA at an MOI of 200 PFU/cell inhibited insulin-induced activation of endogenous Akt by ~90% (26). Because the antibodies to Akt used in our previous study recognize Akt1, Akt2, and Akt3 (26), it was suggested that Akt-AA inhibits all three known isoforms of Akt. Because Akt2 is a major isoform of Akt in 3T3-L1 adipocytes (11), we directly tested the effect of Akt-AA on insulin-stimulated Akt2 activity in 3T3-L1 adipocytes with the use of antibodies to Akt2. These antibodies did not recognize Akt-AA (data not shown), which is derived from rat Akt1. Insulin induced an approximately fivefold increase in kinase activity present in immunoprecipitates prepared with the antibodies to Akt2 (Fig. 11E). The amount of kinase activity in immunoprecipitates prepared with antibodies to Akt3 was not substantially greater than that present in precipitates prepared with control antibodies (data not shown). Infection of 3T3-L1 cells with AxCAAkt-AA at an MOI of 200 PFU/cell inhibited insulin stimulation of Akt2 activity by ~80% (Fig. 11E). However, AxCAAkt-AA had no effect on insulin-stimulated PKClambda activity (Fig. 11F), suggesting that Akt does not contribute to PKClambda activation by insulin.

The inhibitory effect of lambda Delta NKD on insulin-stimulated glucose uptake was partial (~50 to 60%) (Fig. 6B), whereas this mutant almost completely abolished the insulin-induced increase in PKClambda activity (Fig. 5C). These results may suggest the existence of a redundant pathway that mediates insulin stimulation of glucose uptake. To examine whether Akt is responsible for such a redundant pathway, we finally examined the effect of coexpression of lambda KD and Akt-AA on insulin-induced glucose uptake in 3T3-L1 adipocytes. The inhibitory effect of lambda KD on insulin stimulation of glucose uptake in cells infected with AxCAAkt-AA at an MOI of 200 PFU/cell was similar to that apparent in cells not infected with AxCAAkt-AA (Fig. 12).


View larger version (36K):
[in this window]
[in a new window]
  		FIG. 12.   Combined effects of Akt-AA and lambda KD on insulin-induced glucose uptake. 3T3-L1 adipocytes were infected with AxCAlambda KD at the indicated MOI, and after 8 h, they were infected (or not) with AxCAAkt-AA at an MOI of 200 PFU/cell. After 40 h, the cells were assayed for insulin-induced glucose uptake. Data are expressed as a percentage of maximal insulin-induced glucose uptake and are means ± standard errors from three experiments.

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Evidence suggests that stimulation of glucose transport by insulin is mediated mainly by a pathway triggered by PI 3-kinase (12, 20, 21, 39, 41). Because both Akt and atypical PKC isozymes act downstream of PI 3-kinase, it has been of interest to determine whether insulin-stimulated glucose uptake is mediated through one of these protein kinases or through an as-yet-unknown effector of the lipid kinase. To address this question, we have now investigated the role of an atypical PKC isoform, PKClambda , in intact cells by specifically inhibiting the activity of the endogenous enzyme. Overexpression of kinase-deficient mutants of atypical PKC has been shown to inhibit various biological actions, including activation of mitogen-activated protein kinase, DNA synthesis, nuclear factor-kappa B-dependent trans activation, and v-ras-induced transformation (7-9, 15), although it is not clear whether such mutants inhibit the activity of the endogenous enzymes.

We have now shown that expression of kinase-defective mutants of PKClambda (lambda KD and lambda Delta NKD) inhibited insulin-induced activation of both transfected and endogenous PKClambda . Because the insulin-induced increase in PI 3-kinase activity, measured in immunoprecipitates prepared with antibodies to phosphotyrosine, was not affected by either of these mutant proteins, it appears that they do not inhibit the insulin receptor kinase or subsequent phosphorylation of IRS1; rather, they prevent specific signaling downstream of PI 3-kinase. Normal activation of Akt by insulin in cells expressing lambda KD also supports this conclusion. These observations thus demonstrated that lambda KD and lambda Delta NKD act in a dominant negative manner.

Overexpression of either lambda KD or lambda Delta NKD inhibited insulin stimulation of glucose uptake and GLUT4 translocation in 3T3-L1 adipocytes. Basal glucose transport in cells expressing these mutants was similar to that in uninfected cells. Furthermore, glucose uptake induced by either GH or hyperosmolarity attributable to sorbitol, both of which promote glucose transport through a PI 3-kinase-independent mechanism (41), was not affected by lambda KD, suggesting that lambda KD inhibited insulin-induced glucose uptake not by an effect on a component of the transport machinery but by blocking specific signals mediated through PKClambda . Indeed, the amount of GLUT4 protein in cells infected with AxCAlambda KD or AxCAlambda Delta NKD was unchanged.

To investigate further the role of PKClambda in glucose uptake and translocation of GLUT4, we examined the effects of a constitutively active mutant of PKClambda . The kinase activity of lambda Delta PD, a PKClambda mutant that lacks the pseudosubstrate domain, is markedly greater than that of the wild-type enzyme. Infection of cells with AxCAlambda Delta PD stimulated glucose uptake to an extent similar to that achieved by insulin, without affecting the amount of GLUT4 protein or of insulin-stimulated PI 3-kinase activity precipitated with antibodies to phosphotyrosine. The observation that insulin did not result in further stimulation of glucose uptake in these cells suggests that the effects of insulin and PKClambda are not additive and that PKClambda lies on the insulin signaling pathway responsible for regulating glucose uptake. The inability of wortmannin to inhibit glucose transport stimulated by lambda Delta PD is consistent with the conclusion that PKClambda acts downstream of PI 3-kinase. These results, together with the ability of wild-type PKClambda to compensate for the inhibition of insulin-induced glucose uptake by lambda Delta NKD, indicate that PKClambda contributes to insulin stimulation of glucose uptake.

Expression of Akt fused with a viral Gag protein or tagged with a myristoylation signal sequence induced glucose uptake or translocation of GLUT4 in adipocytes (30, 45). Although these observations do not necessarily indicate that insulin signaling to glucose uptake is mediated by Akt, it is important to determine whether Akt and PKClambda participate in the same signaling pathway or whether they transmit signals through different pathways. We have now shown that lambda KD did not inhibit insulin-induced activation of Akt and that lambda Delta PD did not increase basal Akt activity. These data indicate that the inhibitory effect of lambda KD on insulin-stimulated glucose uptake is not mediated by prevention of Akt activation and that lambda Delta PD stimulation of glucose transport is not mediated by activation of Akt. Moreover, we have shown that the inhibition of insulin-induced activation of Akt by a dominant negative mutant of Akt (Akt-AA) did not affect insulin stimulation of PKClambda activity, indicating that insulin activation of PKClambda is independent of Akt activation.

Cong et al. (14) have shown that when isolated adipocytes were transiently transfected with constructs encoding HA-tagged GLUT4 and a kinase-deficient mutant of Akt (Akt-K179A), the amount of HA-tagged GLUT4 on the cell surface, in the absence or presence of insulin, was ~20% less than that apparent in cells that were transfected with a control plasmid in addition to that encoding HA-tagged GLUT4, suggesting that Akt contributes to insulin stimulation of translocation of GLUT4 in these cells. However, we have recently found that overexpression of a similar kinase-deficient mutant of Akt (Akt-K179D) affected neither insulin-stimulated Akt activity in CHO cells (26) nor insulin-stimulated glucose uptake in 3T3-L1 adipocytes (32). We do not know the reason for this discrepancy. It is possible that the effects of kinase-deficient mutants of Akt may be different in different cells and tissues.

The reason why the dominant negative mutants of PKClambda inhibited insulin-stimulated glucose uptake by only ~50% in 3T3-L1 adipocytes, whereas lambda Delta NKD almost completely abolished the insulin-induced increase in PKClambda activity precipitated with antibodies to PKClambda , is not clear. One possibility is that there is a redundant pathway that mediates insulin stimulation of glucose uptake and that prevention of signal transduction by the PKClambda pathway is therefore not sufficient to block glucose uptake completely. It is not known which molecules might be responsible for such a redundant pathway; however, the participation of Akt is unlikely, given that expression of Akt-AA did not exert an additive effect on the inhibition of glucose uptake by lambda KD. Calera et al. (11) have shown that the amount of Akt2 associated with GLUT4-containing vesicles was increased in response to insulin. Although the physiological significance of this observation remains to be elucidated, we cannot exclude the possibility that a small increase in Akt activity in a specific compartment of the cell may be sufficient to activate glucose transport fully. Another possible explanation for the discrepancy between the extents of inhibition of glucose uptake and of PKClambda activity by the dominant negative mutants of PKClambda is that the activity of immunoprecipitated PKClambda does not completely reflect the activity of this enzyme in intact cells. It has been suggested that interaction with lipids produced in response to extracellular stimuli regulates the enzymatic activity of atypical PKC (1, 36-38, 43). Thus, lipids essential for the activation of PKClambda in intact cells may have been removed, at least in part, during immunoprecipitation, possible explaining the relatively small activation of the enzyme observed in the immunoprecipitates. This possibility is supported by our observation that PKClambda immunoprecipitated from insulin-stimulated cells was further activated by PS in vitro (32). Therefore, we cannot exclude the possibility that lambda KD and lambda Delta NKD may not completely block the activity of PKClambda in intact cells, whereas the insulin-induced increase in the activity of the immunoprecipitated enzyme appears to be abolished.

Two groups have reported that PKCzeta is expressed in 3T3-L1 adipocytes on the basis of immunoblot analysis with antibodies generated in response to a peptide corresponding to the COOH-terminal region of rat PKCzeta (GFEYINPLLLSAEESV) (6, 19). This amino acid sequence is highly homologous to the corresponding sequence of mouse PKClambda (GFEYINPLLMSAEECV). We have now shown that antibodies induced by the same COOH-terminal peptide of PKCzeta (alpha zeta CT) recognized mouse PKClambda transiently expressed in COS7 cells. Moreover, alpha zeta CT detected an ~80-kDa protein in immunoprecipitates prepared from 3T3-L1 adipocyte lysates with antibodies to PKClambda (alpha lambda 190) but not in those prepared with antibodies to PKCzeta (alpha zeta 170). These results, together with those of our RT-PCR analysis, suggest that PKClambda , but not PKCzeta , is expressed in 3T3-L1 adipocytes and that the protein previously detected in 3T3-L1 adipocytes by the antibodies to the PKCzeta peptide is actually PKClambda .

Bandyopadhyay et al. (6) have shown that insulin-stimulated glucose uptake was reduced by ~30% in 3T3-L1 adipocytes expressing a kinase-deficient mutant of rat PKCzeta . We have found that overexpression of a kinase-deficient mutant of PKCzeta inhibited the insulin-induced increase in PKClambda activity in 3T3-L1 adipocytes (32), suggesting that the inhibition of glucose transport observed by these investigators may be due to the inhibition of PKClambda . However, it is possible that PKCzeta also participates in insulin signal transduction, because the same group recently reported that transient expression of a kinase-defective mutant PKCzeta in rat adipocytes, or incubation of the adipocytes with a peptide corresponding to the pseudosubstrate domain of PKCzeta , inhibited insulin-induced translocation of transfected GLUT4 or glucose transport, respectively (43). Furthermore, it has been reported that insulin-stimulated protein synthesis in hematopoietic cells was modulated by transfection with a mutant PKCzeta cDNA (34). It is thus important to determine which actions of insulin that are dependent on PI 3-kinase are mediated by which isoform of atypical PKC in different cells and tissues.

In summary, we have shown that PKClambda is required for insulin stimulation of glucose uptake, but not for Akt activation, and that a dominant negative Akt mutant did not affect PKClambda activity in 3T3-L1 adipocytes. These results suggest that insulin-elicited signals that pass through PI 3-kinase are subsequently transmitted by at least two independent pathways: an Akt pathway and a PKClambda pathway. The mechanism by which PKClambda is activated by PI 3-kinase remains unclear. Clarification of the mechanism by which PKClambda is regulated should increase our understanding of the mechanism by which signals from PI 3-kinase diverge and are transmitted by various downstream effectors, subsequently resulting in a broad range of biological effects.

    ACKNOWLEDGMENTS

This work was supported by a grant from the Ministry of Education, Science, Sports, and Culture of Japan, a Grant-in-Aid for Research for the Future Program from the Japan Society for the Promotion of Science, a grant from the Uehara Memorial Foundation, a grant for studies on the pathophysiology and complications of diabetes from Tsumura Pharma Ltd. (to M.K.), and a grant from Suzuken Memorial Foundation (to W.O.).

    FOOTNOTES

* Corresponding author. Mailing address: Second Department of Internal Medicine, Kobe University School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. Phone: 81-78-341-7451. Fax: 81-78-382-2080. E-mail: ogawa{at}med.kobe-u.ac.jp.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1. Akimoto, K., K. Mizuno, S.-I. Osada, S.-I. Hirai, S. Tanuma, K. Suzuki, and S. Ohno. 1994. A new member of the third class in the protein kinase C family, PKClambda , expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J. Biol. Chem. 269:12677-12683[Abstract/Free Full Text].
2. Akimoto, K., R. Takahashi, S. Moriya, N. Nishioka, J. Takayanagi, K. Kimura, Y. Fukui, S.-I. Osada, K. Mizuno, S.-I. Hirai, A. Kazulauskas, and S. Ohno. 1996. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J. 15:788-798[Medline].
3. Alessi, D. R., M. Andjelkovic, B. Caudwell, P. Cron, N. Morrice, P. Cohen, and B. A. Hemmings. 1996. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 15:6541-6551[Medline].
4. Alessi, D. R., S. R. James, C. P. Downes, A. B. Holmes, P. R. Gaffney, C. B. Reese, and P. Cohen. 1997. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha . Curr. Biol. 7:261-269[Medline].
5. Backer, J. M., M. G. Myer, Jr., S. E. Shoelsen, D. J. Chin, X. J. Sun, M. Miralpleix, P. Hu, B. Margolis, E. Y. Skolnik, J. Schlessinger, and M. White. 1992. The phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11:3469-3479[Medline].
6. Bandyopadhyay, G., M. L. Standaert, L. Zhao, Y. Bingzhi, A. Avignon, L. Galloway, P. Karnam, J. Moscat, and R. V. Farese. 1997. Activation of protein kinase C (alpha , beta , and zeta ) by insulin in 3T3/L1 cells. Transfection studies suggest a role for PKC-zeta in glucose transport. J. Biol. Chem. 272:2551-2558[Abstract/Free Full Text].
7. Berra, E., M. T. Diaz-Meco, I. Dominguez, M. M. Municio, L. Sanz, J. Lozano, R. S. Chapkin, and J. Moscat. 1993. Protein kinase Czeta isoform is critical for mitogenic signal transduction. Cell 74:555-563[Medline].
8. Berra, E., M. T. Diaz-Meco, J. Lozano, S. Frutons, M. M. Munico, P. Sánchez, L. Sanz, and J. Moscat. 1995. Evidence for a role of MEK and MAPK during signal transduction by protein kinase Czeta . EMBO J. 14:6157-6163[Medline].
9. Bjørkøy, G., M. Perander, A. Øvervatn, and T. Johansen. 1997. Reversion of Ras- and phosphatidylcholine-hydrolyzing phospholipase C-mediated transformation of NIH 3T3 cells by a dominant interfering mutant of protein kinase Clambda is accompanied by the loss of constitutive nuclear mitogen activated protein kinase/extracellular signal-regulated kinase activity. J. Biol. Chem. 272:11557-11565[Abstract/Free Full Text].
10. Burgering, B. M. T., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602[Medline].
11. Calera, M. R., C. Carmen, H. Liu, A. K. E. Jack, M. J. Birnbaum, and P. F. Pilch. 1998. Insulin increases the association of Akt2 with Glut-4 containing vesicles. J. Biol. Chem. 273:7201-7204[Abstract/Free Full Text].
12. Chang, H. W., M. Aoki, D. Fruman, K. R. Auger, A. Bellacosa, P. N. Tsichlis, L. C. Cantley, T. M. Roberts, and P. K. Vogt. 1997. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276:1848-1850[Abstract/Free Full Text].
13. Cheatham, B., C. J. Vlahos, L. Cheatham, L. Wang, J. Blenis, and C. R. Kahn. 1994. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 14:4902-4911[Abstract/Free Full Text].
14. Cong, L.-N., H. Chen, Y. Li, L. Zhou, M. A. McGibbon, S. I. Taylor, and M. J. Quon. 1997. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol. Endocrinol. 11:1881-1890[Abstract/Free Full Text].
15. Diaz-Meco, M. T., E. Berra, M. M. Municho, L. Sanz, J. Lozano, I. Dominguez, V. Diaz-Golpe, M. T. Lain de Lera, J. Alcami, C. Paya, F. Arezana-Seissedod, J.-L. Virelizier, and J. Moscat. 1993. A dominant negative protein kinase Czeta subspecies blocks NF-kappa B activation. Mol. Cell. Biol. 13:4770-4775[Abstract/Free Full Text].
16. Franke, T. F., S. I. Yang, T. O. Chan, K. Datta, A. Kazlauskas, D. K. Morrison, D. R. Kaplan, and P. N. Tsichlis. 1995. The protein kinase encoded by the AKT protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81:727-736[Medline].
17. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437[Medline].
18. Franke, T. F., D. R. Kaplan, L. C. Cantley, and A. Toker. 1997. Direct binding of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-667[Abstract/Free Full Text].
19. Frevert, E. U., and B. B. Kahn. 1996. Protein kinase C isoforms varepsilon , eta , delta  and zeta  in murine adipocytes: expression, subcellular localization and tissue-specific regulation in insulin-resistant states. Biochem. J. 316:865-871.
20. Frevert, E. U., and B. B. Kahn. 1997. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol. Cell. Biol. 17:190-198[Abstract].
21. Hara, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, P. T. Hawkins, R. Dhand, A. E. Clark, G. D. Holman, M. D. Waterfield, and M. Kasuga. 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for Ras activation in CHO cells. Proc. Natl. Acad. Sci. USA 91:7415-7419[Abstract/Free Full Text].
22. Herrera-Velit, P., K. L. Kuntson, and N. E. Reiner. 1997. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes. J. Biol. Chem. 272:16445-16452[Abstract/Free Full Text].
23. Holman, G. H., and M. Kasuga. 1997. From receptor to transporter: insulin signaling to glucose transport. Diabetologia 40:991-1003[Medline].
24. Kimura, K., S. Hattori, Y. Kabuyama, Y. Shizawa, J. Takayanagi, S. Nakamura, S. Toki, Y. Matsuda, K. Onodera, and Y. Fukui. 1994. Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:18961-18967[Abstract/Free Full Text].
25. Kitamura, Y., T. Kitamura, H. Sakaue, T. Maeda, H. Ueno, S. Nishio, S. Ohno, S.-I. Osada, M. Sakaue, W. Ogawa, and M. Kasuga. 1997. Interaction of Nck-associated protein 1 with activated GTP-binding protein Rac. Biochem. J. 322:873-878.
26. Kitamura, T., W. Ogawa, H. Sakaue, Y. Hino, S. Kuroda, M. Takata, M. Matsumoto, T. Maeda, H. Konishi, U. Kikkawa, and M. Kasuga. 1998. Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18:3708-3717[Abstract/Free Full Text].
27. Klippel, A., C. Reinhard, M. Kavanaugh, G. Apell, M. A. Escobedo, and L. T. Williams. 1996. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol. Cell. Biol. 16:4117-4127[Abstract].
28. Klippel, A., W. M. Kavanaugh, D. Pot, and L. T. Williams. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol. Cell. Biol. 17:338-344[Abstract].
29. Kohn, A. D., K. S. Kovacina, and R. A. Roth. 1995. Insulin stimulates the kinase-activity of RAC-PK, a pleckstrin homology domain-containing Ser/Thr kinase. EMBO J. 14:4288-4295[Medline].
30. Kohn, A. D., S. A. Summers, M. J. Birnbaum, and R. A. Roth. 1996. Expression of constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271:31372-31378[Abstract/Free Full Text].
31. Kohn, A. D., F. Takeuchi, and R. A. Roth. 1996. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271:21920-21926[Abstract/Free Full Text].
32. Kotani, K., W. Ogawa, and M. Kasuga. Unpublished data.
33. Kotani, K., K. Yonezawa, K. Hara, H. Ueda, Y. Kitamura, H. Sakaue, A. Ando, A. Chavanieu, B. Calas, F. Grigorescu, M. Nishiyama, M. D. Waterfield, and M. Kasuga. 1994. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13:2313-2321[Medline].
34. Mendez, R., G. Kollmorgen, M. F. White, and R. E. Rhoads. 1997. Requirement of protein kinase Czeta for stimulation of protein synthesis by insulin. Mol. Cell. Biol. 17:5184-5192[Abstract].
35. Miyake, S., M. Makimura, Y. Kanegae, S. Harada, Y. Sato, K. Takamori, C. Tokuda, and I. Saito. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA terminal protein complex and a cosmid bearing the full length virus genome. Proc. Natl. Acad. Sci. USA 93:1320-1324[Abstract/Free Full Text].
36. Nakanishi, H., K. A. Brewer, and J. H. Exton. 1993. Activation of the zeta  isoenzyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268:13-16[Abstract/Free Full Text].
37. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-613[Abstract/Free Full Text].
38. Ohno, S., Y. Akita, A. Hata, S. Osada, K. Kubo, Y. Konno, K. Akimoto, K. Mizuno, T. Saido, and T. Kuroki. 1991. Structural and functional diversities of a family of signal transducing protein kinases, protein kinase C family; two distinct classes of PKC, conventional cPKC and novel nPKC. Adv. Enzyme Regul. 31:287-303[Medline].
39. Okada, T., Y. Kawano, T. Sakakibara, O. Hazeki, and M. Ui. 1994. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. J. Biol. Chem. 269:3568-3573[Abstract/Free Full Text].
40. Ono, Y., T. Fujii, K. Ogita, U. Kikkawa, K. Igarashi, and Y. Nishizuka. 1989. Protein kinase Czeta subspecies from rat brain: its structure, expression, and properties. Proc. Natl. Acad. Sci. USA 86:3099-3103[Abstract/Free Full Text].
41. Sakaue, H., W. Ogawa, M. Takata, S. Kuroda, K. Kotani, M. Matsumoto, M. Sakaue, S. Nishio, H. Ueno, and M. Kasuga. 1997. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol. Endocrinol. 11:1552-1562[Abstract/Free Full Text].
42. Selbie, L. A., C. Schmitz-Peiffer, Y. Sheng, and T. J. Biden. 1993. Molecular cloning and characterization of PKCiota , an atypical isoform of protein kinase C derived from insulin-secreting cells. J. Biol. Chem. 268:24296-24302[Abstract/Free Full Text].
43. Standaert, M. J., L. Galloway, P. Karnam, G. Bandyopathy, J. Moscat, and R. V. Farese. 1997. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J. Biol. Chem. 272:30075-30082[Abstract/Free Full Text].
44. Stokes, D., L. R. Stephens, T. Copeland, P. R. Gaffney, C. B. Reese, G. F. Painter, A. B. Holmes, F. McCormick, and P. T. Hawkins. 1997. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-570[Abstract/Free Full Text].
45. Tanti, J. F., S. Grillo, T. Gremeaux, P. J. Coffer, E. Van-Obberghen, and Y. Le-Marchand-Brustel. 1997. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology 138:2005-2010[Abstract/Free Full Text].
46. Toker, A., and L. C. Cantley. 1997. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-676[Medline].
47. Ui, M., T. Okada, K. Hazeki, and O. Hazeki. 1995. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20:303-307[Medline].
48. Vanhaesebroeck, B., S. J. Leevers, G. Panaytou, and M. D. Waterfield. 1997. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem. Sci. 22:267-272[Medline].
49. Ways, D. K., P. P. Cook, C. Webste, and P. J. Parker. 1992. Effect of phorbol esters on protein kinase C-zeta . J. Biol. Chem. 267:4799-4805[Abstract/Free Full Text].
50. Welsh, G. I., C. M. Stokes, X. Wang, H. Sakaue, W. Ogawa, M. Kasuga, and C. G. Proud. 1997. Activation of translation initiation factor eIF2B by insulin requires phosphatidylinositol 3-kinase. FEBS Lett. 410:418-422[Medline].

Molecular and Cellular Biology, December 1998, p. 6971-6982, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Yao, X.-H., Nyomba, B. L. G. (2008). Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294: R1797-R1806 [Abstract] [Full Text]  
  • Le Stunff, C., Dechartres, A., Mariot, V., Lotton, C., Trainor, C., Miraglia Del Giudice, E., Meyre, D., Bieche, I., Laurendeau, I., Froguel, P., Zelenika, D., Fallin, D., Lathrop, M., Romeo, P.-H., Bougneres, P. (2008). Association Analysis Indicates That a Variant GATA-Binding Site in the PIK3CB Promoter Is a Cis-Acting Expression Quantitative Trait Locus for This Gene and Attenuates Insulin Resistance in Obese Children. Diabetes 57: 494-502 [Abstract] [Full Text]  
  • Yaspelkis, B. B. III, Lessard, S. J., Reeder, D. W., Limon, J. J., Saito, M., Rivas, D. A., Kvasha, I., Hawley, J. A. (2007). Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 293: E941-E949 [Abstract] [Full Text]  
  • Frosig, C., Sajan, M. P., Maarbjerg, S. J., Brandt, N., Roepstorff, C., Wojtaszewski, J. F. P., Kiens, B., Farese, R. V., Richter, E. A. (2007). Exercise improves phosphatidylinositol-3,4,5-trisphosphate responsiveness of atypical protein kinase C and interacts with insulin signalling to peptide elongation in human skeletal muscle. J. Physiol. 582: 1289-1301 [Abstract] [Full Text]  
  • Yao, X.-H., Gregoire Nyomba, B. L. (2007). Abnormal glucose homeostasis in adult female rat offspring after intrauterine ethanol exposure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R1926-R1933 [Abstract] [Full Text]  
  • Harris, T. E., Huffman, T. A., Chi, A., Shabanowitz, J., Hunt, D. F., Kumar, A., Lawrence, J. C. Jr. (2007). Insulin Controls Subcellular Localization and Multisite Phosphorylation of the Phosphatidic Acid Phosphatase, Lipin 1. J. Biol. Chem. 282: 277-286 [Abstract] [Full Text]  
  • Gonzalez, E., McGraw, T. E. (2006). Insulin Signaling Diverges into Akt-dependent and -independent Signals to Regulate the Recruitment/Docking and the Fusion of GLUT4 Vesicles to the Plasma Membrane. Mol. Biol. Cell 17: 4484-4493 [Abstract] [Full Text]  
  • Wang, L., Rhodes, C. J., Lawrence, J. C. Jr. (2006). Activation of Mammalian Target of Rapamycin (mTOR) by Insulin Is Associated with Stimulation of 4EBP1 Binding to Dimeric mTOR Complex 1. J. Biol. Chem. 281: 24293-24303 [Abstract] [Full Text]  
  • Wong, V., Szeto, L., Uffelman, K., Fantus, I G., Lewis, G. F (2006). Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.. J Endocrinol 190: 441-450 [Abstract] [Full Text]  
  • Sajan, M. P., Rivas, J., Li, P., Standaert, M. L., Farese, R. V. (2006). Repletion of Atypical Protein Kinase C following RNA Interference-mediated Depletion Restores Insulin-stimulated Glucose Transport. J. Biol. Chem. 281: 17466-17473 [Abstract] [Full Text]  
  • Oak, S. A., Tran, C., Pan, G., Thamotharan, M., Devaskar, S. U. (2006). Perturbed skeletal muscle insulin signaling in the adult female intrauterine growth-restricted rat. Am. J. Physiol. Endocrinol. Metab. 290: E1321-E1330 [Abstract] [Full Text]  
  • Liu, L.-Z., Zhao, H.-L., Zuo, J., Ho, S. K.S., Chan, J. C.N., Meng, Y., Fang, F.-D., Tong, P. C.Y. (2006). Protein Kinase C{zeta} Mediates Insulin-induced Glucose Transport through Actin Remodeling in L6 Muscle Cells. Mol. Biol. Cell 17: 2322-2330 [Abstract] [Full Text]  
  • Tao, Y., Maegawa, H., Ugi, S., Ikeda, K., Nagai, Y., Egawa, K., Nakamura, T., Tsukada, S., Nishio, Y., Maeda, S., Kashiwagi, A. (2006). The Transcription Factor AP-2{beta} Causes Cell Enlargement and Insulin Resistance in 3T3-L1 Adipocytes. Endocrinology 147: 1685-1696 [Abstract] [Full Text]  
  • Farese, R. V., Sajan, M. P., Standaert, M. L. (2005). Insulin-Sensitive Protein Kinases (Atypical Protein Kinase C and Protein Kinase B/Akt): Actions and Defects in Obesity and Type II Diabetes. Exp. Biol. Med. 230: 593-605 [Abstract] [Full Text]  
  • Thong, F. S. L., Dugani, C. B., Klip, A. (2005). Turning Signals On and Off: GLUT4 Traffic in the Insulin-Signaling Highway. Physiology 20: 271-284 [Abstract] [Full Text]  
  • Chen, L., Yao, X.-H., Nyomba, B. L. G. (2005). In vivo insulin signaling through PI3-kinase is impaired in skeletal muscle of adult rat offspring exposed to ethanol in utero. J. Appl. Physiol. 99: 528-534 [Abstract] [Full Text]  
  • Bandyopadhyay, G. K., Yu, J. G., Ofrecio, J., Olefsky, J. M. (2005). Increased p85/55/50 Expression and Decreased Phosphotidylinositol 3-Kinase Activity in Insulin-Resistant Human Skeletal Muscle. Diabetes 54: 2351-2359 [Abstract] [Full Text]  
  • Herr, H. J., Bernard, J. R., Reeder, D. W., Rivas, D. A., Limon, J. J., Yaspelkis, B. B. III (2005). Insulin-stimulated plasma membrane association and activation of Akt2, aPKC {zeta} and aPKC {lambda} in high fat fed rodent skeletal muscle. J. Physiol. 565: 627-636 [Abstract] [Full Text]  
  • Chernogubova, E., Hutchinson, D. S., Nedergaard, J., Bengtsson, T. (2005). {alpha}1- and {beta}1-Adrenoceptor Signaling Fully Compensates for {beta}3-Adrenoceptor Deficiency in Brown Adipocyte Norepinephrine-Stimulated Glucose Uptake. Endocrinology 146: 2271-2284 [Abstract] [Full Text]  
  • Bustamante, M., Hasler, U., Kotova, O., Chibalin, A. V., Mordasini, D., Rousselot, M., Vandewalle, A., Martin, P.-Y., Feraille, E. (2005). Insulin potentiates AVP-induced AQP2 expression in cultured renal collecting duct principal cells. Am. J. Physiol. Renal Physiol. 288: F334-F344 [Abstract] [Full Text]  
  • Yuasa, T., Kakuhata, R., Kishi, K., Obata, T., Shinohara, Y., Bando, Y., Izumi, K., Kajiura, F., Matsumoto, M., Ebina, Y. (2004). Platelet-Derived Growth Factor Stimulates Glucose Transport in Skeletal Muscles of Transgenic Mice Specifically Expressing Platelet-Derived Growth Factor Receptor in the Muscle, but It Does Not Affect Blood Glucose Levels. Diabetes 53: 2776-2786 [Abstract] [Full Text]  
  • Ugi, S., Imamura, T., Maegawa, H., Egawa, K., Yoshizaki, T., Shi, K., Obata, T., Ebina, Y., Kashiwagi, A., Olefsky, J. M. (2004). Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes. Mol. Cell. Biol. 24: 8778-8789 [Abstract] [Full Text]  
  • Sajan, M. P., Standaert, M. L., Miura, A., Bandyopadhyay, G., Vollenweider, P., Franklin, D. M., Lea-Currie, R., Farese, R. V. (2004). Impaired Activation of Protein Kinase C-{zeta} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 in Cultured Preadipocyte-Derived Adipocytes and Myotubes of Obese Subjects. J. Clin. Endocrinol. Metab. 89: 3994-3998 [Abstract] [Full Text]  
  • Standaert, M. L., Sajan, M. P., Miura, A., Kanoh, Y., Chen, H. C., Farese, R. V. Jr., Farese, R. V. (2004). Insulin-induced Activation of Atypical Protein Kinase C, but Not Protein Kinase B, Is Maintained in Diabetic (ob/ob and Goto-Kakazaki) Liver: CONTRASTING INSULIN SIGNALING PATTERNS IN LIVER VERSUS MUSCLE DEFINE PHENOTYPES OF TYPE 2 DIABETIC AND HIGH FAT-INDUCED INSULIN-RESISTANT STATES. J. Biol. Chem. 279: 24929-24934 [Abstract] [Full Text]  
  • Zabolotny, J. M., Haj, F. G., Kim, Y.-B., Kim, H.-J., Shulman, G. I., Kim, J. K., Neel, B. G., Kahn, B. B. (2004). Transgenic Overexpression of Protein-tyrosine Phosphatase 1B in Muscle Causes Insulin Resistance, but Overexpression with Leukocyte Antigen-related Phosphatase Does Not Additively Impair Insulin Action. J. Biol. Chem. 279: 24844-24851 [Abstract] [Full Text]  
  • Yoshizaki, T., Maegawa, H., Egawa, K., Ugi, S., Nishio, Y., Imamura, T., Kobayashi, T., Tamura, S., Olefsky, J. M., Kashiwagi, A. (2004). Protein Phosphatase-2C{alpha} as a Positive Regulator of Insulin Sensitivity through Direct Activation of Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes. J. Biol. Chem. 279: 22715-22726 [Abstract] [Full Text]  
  • James, D. J., Salaun, C., Brandie, F. M., Connell, J. M. C., Chamberlain, L. H. (2004). Neomycin Prevents the Wortmannin Inhibition of Insulin-stimulated Glut4 Translocation and Glucose Transport in 3T3-L1 Adipocytes. J. Biol. Chem. 279: 20567-20570 [Abstract] [Full Text]  
  • Weyrich, P., Kapp, K., Niederfellner, G., Melzer, M., Lehmann, R., Haring, H.-U., Lammers, R. (2004). Partitioning-Defective Protein 6 Regulates Insulin-Dependent Glycogen Synthesis via Atypical Protein Kinase C. Mol. Endocrinol. 18: 1287-1300 [Abstract] [Full Text]  
  • Watson, R. T., Kanzaki, M., Pessin, J. E. (2004). Regulated Membrane Trafficking of the Insulin-Responsive Glucose Transporter 4 in Adipocytes. Endocr. Rev. 25: 177-204 [Abstract] [Full Text]  
  • NANDI, A., KITAMURA, Y., KAHN, C. R., ACCILI, D. (2004). Mouse Models of Insulin Resistance. Physiol. Rev. 84: 623-647 [Abstract] [Full Text]  
  • Bandyopadhyay, G., Standaert, M. L., Sajan, M. P., Kanoh, Y., Miura, A., Braun, U., Kruse, F., Leitges, M., Farese, R. V. (2004). Protein Kinase C-{lambda} Knockout in Embryonic Stem Cells and Adipocytes Impairs Insulin-Stimulated Glucose Transport. Mol. Endocrinol. 18: 373-383 [Abstract] [Full Text]  
  • Kanzaki, M., Mora, S., Hwang, J. B., Saltiel, A. R., Pessin, J. E. (2004). Atypical protein kinase C (PKC{zeta}/{lambda}) is a convergent downstream target of the insulin-stimulated phosphatidylinositol 3-kinase and TC10 signaling pathways. JCB 164: 279-290 [Abstract] [Full Text]  
  • Perrini, S., Natalicchio, A., Laviola, L., Belsanti, G., Montrone, C., Cignarelli, A., Minielli, V., Grano, M., De Pergola, G., Giorgino, R., Giorgino, F. (2004). Dehydroepiandrosterone Stimulates Glucose Uptake in Human and Murine Adipocytes by Inducing GLUT1 and GLUT4 Translocation to the Plasma Membrane. Diabetes 53: 41-52 [Abstract] [Full Text]  
  • Chernogubova, E., Cannon, B., Bengtsson, T. (2004). Norepinephrine Increases Glucose Transport in Brown Adipocytes via {beta}3-Adrenoceptors through a cAMP, PKA, and PI3-Kinase-Dependent Pathway Stimulating Conventional and Novel PKCs. Endocrinology 145: 269-280 [Abstract] [Full Text]  
  • Sakaue, H., Nishizawa, A., Ogawa, W., Teshigawara, K., Mori, T., Takashima, Y., Noda, T., Kasuga, M. (2003). Requirement for 3-Phosphoinositide-dependent Kinase-1 (PDK-1) in Insulin-induced Glucose Uptake in Immortalized Brown Adipocytes. J. Biol. Chem. 278: 38870-38874 [Abstract] [Full Text]  
  • Whiteman, E. L., Chen, J. J., Birnbaum, M. J. (2003). Platelet-Derived Growth Factor (PDGF) Stimulates Glucose Transport in 3T3-L1 Adipocytes Overexpressing PDGF Receptor by a Pathway Independent of Insulin Receptor Substrates. Endocrinology 144: 3811-3820 [Abstract] [Full Text]  
  • Spurlin, B. A., Thomas, R. M., Nevins, A. K., Kim, H.-J., Kim, Y.-J., Noh, H.-L., Shulman, G. I., Kim, J. K., Thurmond, D. C. (2003). Insulin Resistance in Tetracycline-Repressible Munc18c Transgenic Mice. Diabetes 52: 1910-1917 [Abstract] [Full Text]  
  • Beeson, M., Sajan, M. P., Dizon, M., Grebenev, D., Gomez-Daspet, J., Miura, A., Kanoh, Y., Powe, J., Bandyopadhyay, G., Standaert, M. L., Farese, R. V. (2003). Activation of Protein Kinase C-{zeta} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 Is Defective in Muscle in Type 2 Diabetes and Impaired Glucose Tolerance: Amelioration by Rosiglitazone and Exercise. Diabetes 52: 1926-1934 [Abstract] [Full Text]  
  • Kim, Y.-B., Kotani, K., Ciaraldi, T. P., Henry, R. R., Kahn, B. B. (2003). Insulin-Stimulated Protein Kinase C {lambda}/{zeta} Activity Is Reduced in Skeletal Muscle of Humans With Obesity and Type 2 Diabetes: Reversal With Weight Reduction. Diabetes 52: 1935-1942 [Abstract] [Full Text]  
  • Katome, T., Obata, T., Matsushima, R., Masuyama, N., Cantley, L. C., Gotoh, Y., Kishi, K., Shiota, H., Ebina, Y. (2003). Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions. J. Biol. Chem. 278: 28312-28323 [Abstract] [Full Text]  
  • Imamura, T., Huang, J., Usui, I., Satoh, H., Bever, J., Olefsky, J. M. (2003). Insulin-Induced GLUT4 Translocation Involves Protein Kinase C-{lambda}-Mediated Functional Coupling between Rab4 and the Motor Protein Kinesin. Mol. Cell. Biol. 23: 4892-4900 [Abstract] [Full Text]  
  • Gual, P., Gonzalez, T., Gremeaux, T., Barres, R., Le Marchand-Brustel, Y., Tanti, J.-F. (2003). Hyperosmotic Stress Inhibits Insulin Receptor Substrate-1 Function by Distinct Mechanisms in 3T3-L1 Adipocytes. J. Biol. Chem. 278: 26550-26557 [Abstract] [Full Text]  
  • Bosch, R. R., Bazuine, M., Wake, M. M., Span, P. N., Olthaar, A. J., Schurmann, A., Maassen, J. A., Hermus, A. R. M. M., Willems, P. H. G. M., Sweep, C. G. J. (2003). Inhibition of Protein Kinase C{beta}II Increases Glucose Uptake in 3T3-L1 Adipocytes through Elevated Expression of Glucose Transporter 1 at the Plasma Membrane. Mol. Endocrinol. 17: 1230-1239 [Abstract] [Full Text]  
  • Jiang, Z. Y., Zhou, Q. L., Coleman, K. A., Chouinard, M., Boese, Q., Czech, M. P. (2003). Insulin signaling through Akt/protein kinase B analyzed by small interfering RNA-mediated gene silencing. Proc. Natl. Acad. Sci. USA 100: 7569-7574 [Abstract] [Full Text]  
  • Usui, I., Imamura, T., Huang, J., Satoh, H., Olefsky, J. M. (2003). Cdc42 Is a Rho GTPase Family Member That Can Mediate Insulin Signaling to Glucose Transport in 3T3-L1 Adipocytes. J. Biol. Chem. 278: 13765-13774 [Abstract] [Full Text]  
  • Asante-Appiah, E., Kennedy, B. P. (2003). Protein tyrosine phosphatases: the quest for negative regulators of insulin action. Am. J. Physiol. Endocrinol. Metab. 284: E663-E670 [Abstract] [Full Text]  
  • Kanoh, Y., Sajan, M. P., Bandyopadhyay, G., Miura, A., Standaert, M. L., Farese, R. V. (2003). Defective Activation of Atypical Protein Kinase C {zeta} and {lambda} by Insulin and Phosphatidylinositol-3,4,5-(PO4)3 in Skeletal Muscle of Rats Following High-Fat Feeding and Streptozotocin-Induced Diabetes. Endocrinology 144: 947-954 [Abstract] [Full Text]  
  • Suzuki, A., Akimoto, K., Ohno, S. (2003). Protein Kinase C {lambda}/{iota} (PKC{lambda}/{iota}): A PKC Isotype Essential for the Development of Multicellular Organisms. J Biochem 133: 9-16 [Abstract] [Full Text]  
  • Egawa, K., Maegawa, H., Shi, K., Nakamura, T., Obata, T., Yoshizaki, T., Morino, K., Shimizu, S., Nishio, Y., Suzuki, E., Kashiwagi, A. (2002). Membrane Localization of 3-Phosphoinositide-dependent Protein Kinase-1 Stimulates Activities of Akt and Atypical Protein Kinase C but Does Not Stimulate Glucose Transport and Glycogen Synthesis in 3T3-L1 Adipocytes. J. Biol. Chem. 277: 38863-38869 [Abstract] [Full Text]  
  • Kayali, A. G., Austin, D. A., Webster, N. J. G. (2002). Rottlerin Inhibits Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes by Uncoupling Mitochondrial Oxidative Phosphorylation. Endocrinology 143: 3884-3896 [Abstract] [Full Text]  
  • Standaert, M. L., Ortmeyer, H. K., Sajan, M. P., Kanoh, Y., Bandyopadhyay, G., Hansen, B. C., Farese, R. V. (2002). Skeletal Muscle Insulin Resistance in Obesity-Associated Type 2 Diabetes in Monkeys Is Linked to a Defect in Insulin Activation of Protein Kinase C-{zeta}/{lambda}/{iota}. Diabetes 51: 2936-2943 [Abstract] [Full Text]  
  • Kim, Y.-B., Shulman, G. I., Kahn, B. B. (2002). Fatty Acid Infusion Selectively Impairs Insulin Action on Akt1 and Protein Kinase C lambda /zeta but Not on Glycogen Synthase Kinase-3. J. Biol. Chem. 277: 32915-32922 [Abstract] [Full Text]  
  • Zierath, J. R. (2002). Exercise Effects of Muscle Insulin Signaling and Action: Invited Review: Exercise training-induced changes in insulin signaling in skeletal muscle. J. Appl. Physiol. 93: 773-781 [Abstract] [Full Text]  
  • Hori, H., Sasaoka, T., Ishihara, H., Wada, T., Murakami, S., Ishiki, M., Kobayashi, M. (2002). Association of SH2-Containing Inositol Phosphatase 2 With the Insulin Resistance of Diabetic db/db Mice. Diabetes 51: 2387-2394 [Abstract] [Full Text]  
  • Tsuru, M., Katagiri, H., Asano, T., Yamada, T., Ohno, S., Ogihara, T., Oka, Y. (2002). Role of PKC isoforms in glucose transport in 3T3-L1 adipocytes: insignificance of atypical PKC. Am. J. Physiol. Endocrinol. Metab. 283: E338-E345 [Abstract] [Full Text]  
  • Ducluzeau, P.-H., Fletcher, L. M., Welsh, G. I., Tavare, J. M. (2002). Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles. J. Cell Sci. 115: 2857-2866 [Abstract] [Full Text]  
  • Kanzaki, M., Pessin, J. E. (2002). Caveolin-associated Filamentous Actin (Cav-actin) Defines a Novel F-actin Structure in Adipocytes. J. Biol. Chem. 277: 25867-25869 [Abstract] [Full Text]  
  • Farese, R. V. (2002). Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am. J. Physiol. Endocrinol. Metab. 283: E1-E11 [Abstract] [Full Text]  
  • Chen, H. C., Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Standaert, M., Farese, R. V. Jr., Farese, R. V. (2002). Activation of the ERK Pathway and Atypical Protein Kinase C Isoforms in Exercise- and Aminoimidazole-4-carboxamide- 1-beta -D-riboside (AICAR)-stimulated Glucose Transport. J. Biol. Chem. 277: 23554-23562 [Abstract] [Full Text]  
  • Yamada, T., Katagiri, H., Asano, T., Tsuru, M., Inukai, K., Ono, H., Kodama, T., Kikuchi, M., Oka, Y. (2002). Role of PDK1 in insulin-signaling pathway for glucose metabolism in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 282: E1385-E1394 [Abstract] [Full Text]  
  • Katagiri, H., Asano, T., Yamada, T., Aoyama, T., Fukushima, Y., Kikuchi, M., Kodama, T., Oka, Y. (2002). Acyl-Coenzyme A Dehydrogenases Are Localized on GLUT4-Containing Vesicles via Association with Insulin-Regulated Aminopeptidase in a Manner Dependent on Its Dileucine Motif. Mol. Endocrinol. 16: 1049-1059 [Abstract] [Full Text]  
  • Standaert, M. L., Kanoh, Y., Sajan, M. P., Bandyopadhyay, G., Farese, R. V. (2002). Cbl, IRS-1, and IRS-2 Mediate Effects of Rosiglitazone on PI3K, PKC-{lambda}, and Glucose Transport in 3T3/L1 Adipocytes. Endocrinology 143: 1705-1716 [Abstract] [Full Text]  
  • Vosseller, K., Wells, L., Lane, M. D., Hart, G. W. (2002). Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 99: 5313-5318 [Abstract] [Full Text]  
  • Shioi, T., McMullen, J. R., Kang, P. M., Douglas, P. S., Obata, T., Franke, T. F., Cantley, L. C., Izumo, S. (2002). Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice. Mol. Cell. Biol. 22: 2799-2809 [Abstract] [Full Text]  
  • Letiges, M., Plomann, M., Standaert, M. L., Bandyopadhyay, G., Sajan, M. P., Kanoh, Y., Farese, R. V. (2002). Knockout of PKC{alpha} Enhances Insulin Signaling Through PI3K. Mol. Endocrinol. 16: 847-858 [Abstract] [Full Text]  
  • Vollenweider, P., Menard, B., Nicod, P. (2002). Insulin Resistance, Defective Insulin Receptor Substrate 2--Associated Phosphatidylinositol-3' Kinase Activation, and Impaired Atypical Protein Kinase C ({zeta}/{lambda}) Activation in Myotubes From Obese Patients With Impaired Glucose Tolerance. Diabetes 51: 1052-1059 [Abstract] [Full Text]  
  • Barnes, K., Ingram, J. C., Porras, O. H., Barros, L. F., Hudson, E. R., Fryer, L. G. D., Foufelle, F., Carling, D., Hardie, D. G., Baldwin, S. A. (2002). Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J. Cell Sci. 115: 2433-2442 [Abstract] [Full Text]  
  • Kruszynska, Y. T., Worrall, D. S., Ofrecio, J., Frias, J. P., Macaraeg, G., Olefsky, J. M. (2002). Fatty Acid-Induced Insulin Resistance: Decreased Muscle PI3K Activation But Unchanged Akt Phosphorylation. J. Clin. Endocrinol. Metab. 87: 226-234 [Abstract] [Full Text]  
  • Somwar, R., Niu, W., Kim, D. Y., Sweeney, G., Randhawa, V. K., Huang, C., Ramlal, T., Klip, A. (2001). Differential Effects of Phosphatidylinositol 3-Kinase Inhibition on Intracellular Signals Regulating GLUT4 Translocation and Glucose Transport. J. Biol. Chem. 276: 46079-46087 [Abstract] [Full Text]  
  • Boileau, P., Cauzac, M., Pereira, M. A., Girard, J., Hauguel-de Mouzon, S. (2001). Dissociation between Insulin-Mediated Signaling Pathways and Biological Effects in Placental Cells: Role of Protein Kinase B and MAPK Phosphorylation. Endocrinology 142: 3974-3979 [Abstract] [Full Text]  
  • Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M., Kobayashi, M. (2001). Mammalian Target of Rapamycin Pathway Regulates Insulin Signaling via Subcellular Redistribution of Insulin Receptor Substrate 1 and Integrates Nutritional Signals and Metabolic Signals of Insulin. Mol. Cell. Biol. 21: 5050-5062 [Abstract] [Full Text]  
  • Tremblay, F., Lavigne, C., Jacques, H., Marette, A. (2001). Defective Insulin-Induced GLUT4 Translocation in Skeletal Muscle of High Fat-Fed Rats Is Associated With Alterations in Both Akt/Protein Kinase B and Atypical Protein Kinase C ({zeta}/{lambda}) Activities. Diabetes 50: 1901-1910 [Abstract] [Full Text]  
  • Ricupero, D. A., Poliks, C. F., Rishikof, D. C., Cuttle, K. A., Kuang, P.-P., Goldstein, R. H. (2001). Phosphatidylinositol 3-kinase-dependent stabilization of {alpha}1(I) collagen mRNA in human lung fibroblasts. Am. J. Physiol. Cell Physiol. 281: C99-C105 [Abstract] [Full Text]  
  • Orlicky, D. J., DeGregori, J., Schaack, J. (2001). Construction of stable coxsackievirus and adenovirus receptor-expressing 3T3-L1 cells. J. Lipid Res. 42: 910-915 [Abstract] [Full Text]  
  • Oku, A., Nawano, M., Ueta, K., Fujita, T., Umebayashi, I., Arakawa, K., Kano-Ishihara, T., Saito, A., Anai, M., Funaki, M., Kikuchi, M., Oka, Y., Asano, T. (2001). Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 280: E816-E824 [Abstract] [Full Text]  
  • Tang, X.-h., Shay, N. F. (2001). Zinc Has an Insulin-Like Effect on Glucose Transport Mediated by Phosphoinositol-3-Kinase and Akt in 3T3-L1 Fibroblasts and Adipocytes. J. Nutr. 131: 1414-1420 [Abstract] [Full Text]  
  • Kanoh, Y., Bandyopadhyay, G., Sajan, M. P., Standaert, M. L., Farese, R. V. (2001). Rosiglitazone, Insulin Treatment, and Fasting Correct Defective Activation of Protein Kinase C-{{zeta}}/{{lambda}} by Insulin in Vastus Lateralis Muscles and Adipocytes of Diabetic Rats. Endocrinology 142: 1595-1605 [Abstract] [Full Text]  
  • Farese, R. V. (2001). Insulin-Sensitive Phospholipid Signaling Systems and Glucose Transport. Update II. Exp. Biol. Med. 226: 283-295 [Abstract] [Full Text]  
  • Suzuki, A., Yamanaka, T., Hirose, T., Manabe, N., Mizuno, K., Shimizu, M., Akimoto, K., Izumi, Y., Ohnishi, T., Ohno, S. (2001). Atypical Protein Kinase C Is Involved in the Evolutionarily Conserved Par Protein Complex and Plays a Critical Role in Establishing Epithelia-Specific Junctional Structures. JCB 152: 1183-1196 [Abstract] [Full Text]  
  • Orlicky, D. J., Schaack, J. (2001). Adenovirus transduction of 3T3-L1 cells. J. Lipid Res. 42: 460-466 [Abstract] [Full Text]  
  • Kido, Y., Nakae, J., Accili, D. (2001). The Insulin Receptor and Its Cellular Targets. J. Clin. Endocrinol. Metab. 86: 972-979 [Abstract] [Full Text]  
  • Wada, T., Sasaoka, T., Funaki, M., Hori, H., Murakami, S., Ishiki, M., Haruta, T., Asano, T., Ogawa, W., Ishihara, H., Kobayashi, M. (2001). Overexpression of SH2-Containing Inositol Phosphatase 2 Results in Negative Regulation of Insulin-Induced Metabolic Actions in 3T3-L1 Adipocytes via Its 5'-Phosphatase Catalytic Activity. Mol. Cell. Biol. 21: 1633-1646 [Abstract] [Full Text]  
  • Matthaei, S., Stumvoll, M., Kellerer, M., Häring, H.-U. (2000). Pathophysiology and Pharmacological Treatment of Insulin Resistance. Endocr. Rev. 21: 585-618 [Abstract] [Full Text]  
  • Toker, A. (2000). Protein Kinases as Mediators of Phosphoinositide 3-Kinase Signaling. Mol. Pharmacol. 57: 652-658 [Full Text]  
  • Kanzaki, M., Watson, R. T., Artemyev, N. O., Pessin, J. E. (2000). The Trimeric GTP-binding Protein (Gq/G11) alpha Subunit Is Required for Insulin-stimulated GLUT4 Translocation in 3T3L1 Adipocytes. J. Biol. Chem. 275: 7167-7175 [Abstract] [Full Text]  
  • Sims, K. D., Straff, D. J., Robinson, M. B. (2000). Platelet-derived Growth Factor Rapidly Increases Activity and Cell Surface Expression of the EAAC1 Subtype of Glutamate Transporter through Activation of Phosphatidylinositol 3-Kinase. J. Biol. Chem. 275: 5228-5237 [Abstract] [Full Text]  
  • Yang, C., Watson, R. T., Elmendorf, J. S., Sacks, D. B., Pessin, J. E. (2000). Calmodulin Antagonists Inhibit Insulin-Stimulated GLUT4 (Glucose Transporter 4) Translocation by Preventing the Formation of Phosphatidylinositol 3,4,5-Trisphosphate in 3T3L1 Adipocytes. Mol. Endocrinol. 14: 317-326 [Abstract] [Full Text]  
  • Klein, J., Fasshauer, M., Ito, M., Lowell, B. B., Benito, M., Kahn, C. R. (1999). beta 3-Adrenergic Stimulation Differentially Inhibits Insulin Signaling and Decreases Insulin-induced Glucose Uptake in Brown Adipocytes. J. Biol. Chem. 274: 34795-34802 [Abstract] [Full Text]  
  • Imamura, T., Ishibashi, K.-i., Dalle, S., Ugi, S., Olefsky, J. M. (1999). Endothelin-1-induced GLUT4 Translocation Is Mediated via Galpha q/11 Protein and Phosphatidylinositol 3-Kinase in 3T3-L1 Adipocytes. J. Biol. Chem. 274: 33691-33695 [Abstract] [Full Text]  
  • Hill, M. M., Clark, S. F., Tucker, D. F., Birnbaum, M. J., James, D. E., Macaulay, S. L. (1999). A Role for Protein Kinase Bbeta /Akt2 in Insulin-Stimulated GLUT4 Translocation in Adipocytes. Mol. Cell. Biol. 19: 7771-7781 [Abstract] [Full Text]  
  • Sajan, M. P., Standaert, M. L., Bandyopadhyay, G., Quon, M. J., Burke, T. R. Jr., Farese, R. V. (1999). Protein Kinase C-zeta and Phosphoinositide-dependent Protein Kinase-1 Are Required for Insulin-induced Activation of ERK in Rat Adipocytes. J. Biol. Chem. 274: 30495-30500 [Abstract] [Full Text]  
  • Imamura, T., Vollenweider, P., Egawa, K., Clodi, M., Ishibashi, K., Nakashima, N., Ugi, S., Adams, J. W., Brown, J. H., Olefsky, J. M. (1999). G Alpha-q/11 Protein Plays a Key Role in Insulin-Induced Glucose Transport in 3T3-L1 Adipocytes. Mol. Cell. Biol. 19: 6765-6774 [Abstract] [Full Text]  
  • Bandyopadhyay, G., Standaert, M. L., Sajan, M. P., Karnitz, L. M., Cong, L., Quon, M. J., Farese, R. V. (1999). Dependence of Insulin-Stimulated Glucose Transporter 4 Translocation on 3-Phosphoinositide-Dependent Protein Kinase-1 and Its Target Threonine-410 in the Activation Loop of Protein Kinase C-{zeta}. Mol. Endocrinol. 13: 1766-1772 [Abstract] [Full Text]  
  • Lavoie, L., Band, C. J., Kong, M., Bergeron, J. J. M., Posner, B. I. (1999). Regulation of Glycogen Synthase in Rat Hepatocytes. EVIDENCE FOR MULTIPLE SIGNALING PATHWAYS. J. Biol. Chem. 274: 28279-28285 [Abstract] [Full Text]  
  • Standaert, M. L., Bandyopadhyay, G., Perez, L., Price, D., Galloway, L., Poklepovic, A., Sajan, M. P., Cenni, V., Sirri, A., Moscat, J., Toker, A., Farese, R. V. (1999). Insulin Activates Protein Kinases C-zeta and C-lambda by an Autophosphorylation-dependent Mechanism and Stimulates Their Translocation to GLUT4 Vesicles and Other Membrane Fractions in Rat Adipocytes. J. Biol. Chem. 274: 25308-25316 [Abstract] [Full Text]  
  • Kitamura, T., Kitamura, Y., Kuroda, S., Hino, Y., Ando, M., Kotani, K., Konishi, H., Matsuzaki, H., Kikkawa, U., Ogawa, W., Kasuga, M. (1999). Insulin-Induced Phosphorylation and Activation of Cyclic Nucleotide Phosphodiesterase 3B by the Serine-Threonine Kinase Akt. Mol. Cell. Biol. 19: 6286-6296 [Abstract] [Full Text]  
  • Etgen, G. J., Valasek, K. M., Broderick, C. L., Miller, A. R. (1999). In Vivo Adenoviral Delivery of Recombinant Human Protein Kinase C-zeta Stimulates Glucose Transport Activity in Rat Skeletal Muscle. J. Biol. Chem. 274: 22139-22142 [Abstract] [Full Text]  
  • Kotani, K., Ogawa, W., Hino, Y., Kitamura, T., Ueno, H., Sano, W., Sutherland, C., Granner, D. K., Kasuga, M. (1999). Dominant Negative Forms of Akt (Protein Kinase B) and Atypical Protein Kinase Clambda Do Not Prevent Insulin Inhibition of Phosphoenolpyruvate Carboxykinase Gene Transcription. J. Biol. Chem. 274: 21305-21312 [Abstract] [Full Text]  
  • Shepherd, P. R., Kahn, B. B. (1999). Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus. NEJM 341: 248-257 [Full Text]  
  • Takata, M., Ogawa, W., Kitamura, T., Hino, Y., Kuroda, S., Kotani, K., Klip, A., Gingras, A.-C., Sonenberg, N., Kasuga, M. (1999). Requirement for Akt (Protein Kinase B) in Insulin-induced Activation of Glycogen Synthase and Phosphorylation of 4E-BP1 (PHAS-1). J. Biol. Chem. 274: 20611-20618 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotani, K.
Right arrow Articles by Kasuga, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotani, K.
Right arrow Articles by Kasuga, M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»